Characterization of the T4 Mre11/Rad50 complex and investigation of the Mre11 dimeric interface by Albrecht, Dustin William
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2012
Characterization of the T4 Mre11/Rad50 complex
and investigation of the Mre11 dimeric interface
Dustin William Albrecht
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Biochemistry Commons
This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital
Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital
Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Albrecht, Dustin William, "Characterization of the T4 Mre11/Rad50 complex and investigation of the Mre11 dimeric interface"
(2012). Graduate Theses and Dissertations. 12671.
https://lib.dr.iastate.edu/etd/12671
Characterization of the T4 Mre11/Rad50 complex and investigation of the Mre11 
dimeric interface 
by 
Dustin William Albrecht 
 
A thesis submitted to the graduate faculty in partial  
fulfillment of the requirements for the degree of 
MASTER OF SCIENCE 
 
Major: Biochemistry 
Program of Study Committee: 
Scott Nelson, Major Professor 
Michael Shogren-Knaak 
Drena Dobbs 
 
Iowa State University 
Ames, Iowa 
2012 
 
Copyright © Dustin William Albrecht, 2012.  All rights reserved. 
 
 
ii 
 
 
Table of Contents 
Chapter I:  Introduction 1 
 General Introduction 1 
 Thesis Outline 5 
 References 6 
 Figures 9 
Chapter II:  Biochemical Characterization of Bacteriophage T4 Mre11-Rad50 Complex 11 
 Abstract 11 
 Introduction 12 
 Experimental Procedures 16 
 Results 21 
 Discussion 29 
 Acknowledgments 36 
 Footnotes 36 
 References 36 
 Tables and Figures 40 
Chapter III:  Disruption of Bacteriophage T4 Mre11 Dimer Interface Reveals Two-State 
Mechanism for Exonuclease Activity 
49 
 Abstract 49 
 Introduction 50 
 Experimental Procedures 54 
 Results 60 
 Discussion 66 
 Acknowledgements 73 
 Footnotes 73 
 References 73 
 Tables and Figures 76 
Chapter IV:  Conclusions 88 
 Summary 88 
 Future Direction 90 
 Acknowledgements 91 
 References 91 
1 
 
 
Chapter I:  Introduction 
General Introduction 
 Double-strand breaks (DSB) in DNA are one of the most harmful forms of DNA 
damage and may lead to genomic instability or cell death if they are not repaired efficiently 
(1).  DSBs are formed through both internal and external causes.  External causes include UV 
radiation, ionizing radiation (IR), and genotoxic chemicals including chemotherapeutic 
drugs.  Internal causes of DSBs include reactive oxygen species, protein complexes that 
inhibit replication fork progression, and the deliberate formation during VDJ recombination 
in antibody development (2). 
 In eukaryotes there are three pathways for the repair of DSBs which have been 
described previously: homologous recombination (HR), non-homologous end-joining 
(NHEJ), and microhomology-mediated end-joining (MMEJ) (3).  Mre11and Rad50 (MR 
complex hereafter) are involved in all three of these pathways (3, 4).  The pathway that is 
used is dependent on the nature of the broken ends and the phase of the cell cycle.  DSBs that 
have a 3’ hydroxyl and a 5’ phosphate group are termed “clean” breaks and require no further 
processing before ligation.  This kind of break is the only type that is suitable for repair via 
NHEJ.  The Ku70/Ku80 complex that initiates NHEJ does not have a high affinity for breaks 
with more extensive damage or that have proteins bound.  These types of breaks require 
processing (i.e. resection) and are thus candidates for HR or MMEJ (5).  Repair through HR 
is prevalent during the S and G2 phases of the cell cycle due to the presence of replicated 
DNA and the availability of sister chromatids (5).  NHEJ is active throughout the entire cell 
cycle but is the preferred mechanism during G1.  MMEJ is also active throughout the whole 
cell cycle.  A summary of this regulation is shown in Figure 1 (5). 
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The MR complex is heterotetrameric (M2/R2) and its role is best understood in the 
context of HR.  Homologous recombination is a multi-step process that requires a number of 
proteins and is thought to be largely error-free (6).  It is best understood in the 
Saccharomyces cerevisiae model system and the role of the MR complex has recently been 
explained in the literature (7-9).  The MR complex works along with Xrs2 and Sae2 to 
perform the initial short range (50-100 nucleotides) resection of the 5’ end to create a 3’ 
overhang (7).  After this initial processing, a more extensive resection (>500 nucleotides) is 
performed by Sgs1/Top3/Rmi1/Dna2 and RPA or Exo1 and RPA.  Once resection is 
completed, Rad51 binds to the 3’ ssDNA tail, performs a search for homologous sequences, 
and promotes strand invasion into the homologous DNA.  This creates a D-loop and 
formation of the D-loop allows the non-invading strand of the DSB to pair with the other 
strand of the homologous DNA.  Both 3’ ends from the DSB are then used as primers for 
DNA synthesis, ultimately forming a pair of Holliday junctions (10, 11).  After completion of 
DNA synthesis, the elongated strands are released by a DNA helicase or the Holliday 
junctions are resolved by a DNA nuclease and a ligase. 
Homologous recombination in prokaryotes is performed following steps similar to 
those in eukaryotes (i.e. damage recognition, end processing, homology search/annealing, 
and DNA synthesis/strand dissocation) (12).  Although there is are Mre11 and Rad50 
homologs in prokaryotes they do not seem to be involved in DNA end resection.  Prokaryotic 
resection is instead carried out by the RecBCD helicase/nuclease complex (13). 
 The role of the MR complex in NHEJ is less understood than in HR.  NHEJ is a fairly 
simple process in which a heterodimer of Ku70 and Ku80 binds to the DNA ends with a high 
affinity and effectively blocks resection (14).  The Ku heterodimer is also required for 
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recruitment of Dnl4 and the ligase-accessory protein Nej1 (15).  The role of the MR complex 
in NHEJ is not completely defined although it has been implicated in bridging the ends of 
DNA and also the dissociation of the Ku heterodimer and Nej1 (15, 16). 
 The MR complex is also involved in MMEJ.  MMEJ is an error-prone mechanism for 
repairing DSBs and utilizes small (5-25 base pair) sequences of microhomology (3).  MMEJ 
begins in S. cerevisiae in much the same way as HR does, with the MR complex and Xrs2 
performing 5’ resection at the site of the DSB.  Once resected, Srs2 displaces Rad51 coating 
the ssDNA and regions of microhomology are annealed together (17).  Before gap fill-in and 
ligation can occur, the 3’ flaps that are outside of the microhomologous region must be 
trimmed by the Rad1-Rad10 endonuclease, resulting in a deletion compared to the original 
sequence (17).  The resulting gaps are then filled in via DNA synthesis with Pol4 and Polγ 
both implicated in this process.  Finally, the ends are ligated together by either Cdc9 or Dnl4.  
Another pathway which involves multiple rounds of annealing of microhomologies, DNA 
synthesis, and dissociation of DNA strands has been proposed and is demonstrated in Figure 
2 (3). 
 The MR complex is present in eukaryotes, prokaryotes, archaea, and bacteriophage 
biological systems and performs DSB resection in all of these systems except prokaryotes.  
As previously discussed, the MR complex has an important role in the repair of DSBs.  
Therefore it is not surprising that diseases can be attributed to a dysfunctional MR complex 
phenotype.  Mre11 deficiency has been linked to ataxia telangiectasia-like disorder (ATLD), 
IR sensitivity, and cerebellar dysfunction (18).  Likewise, Rad50 has been linked to cancers 
and Nigmen breakage syndrome-like disorder (19, 20). 
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Rad50 is a member of structural maintenance of chromosomes (SMC) protein family.  
SMC proteins are a subset of the ATP Binding Cassette (ABC) protein superfamily which is 
highly conserved and abundant in all organisms (21, 22).  ABC proteins form dimers and 
bind/hydrolyze ATP at the dimeric interface.  There are six conserved motifs in the ABC 
protein family; the Walker A motif, Walker B motif, Q-loop, H-loop, D-loop, and Signature 
motif.  The dimer is in a head-to-tail formation with the Walker A, Walker B, Q-loop, and H-
loop motifs from one monomer and the D-loop and Signature motifs from the other monomer 
forming the ATPase active site (23).  The structure of the ATPase active site of Pyrococcus 
furious (Pfu) has been solved in apo-, ATP-bound, and AMP-PNP-bound forms (24).  The 
hydrolysis of ATP in ABC proteins is often coupled to an associated protein with Mre11 
being the protein coupled to Rad50 (21, 25).  In addition to the six motifs seen in ABC 
proteins, Rad50 has a long coiled-coil region that contains a conserved Cys-X-X-Cys motif.  
This motif dimerizes with another Rad50 monomer to create a zinc binding site (26).  The 
function of the coiled-coil motif is not well defined but may play a role in tethering the DNA 
ends separated by the DSB (4). 
 Mre11 belongs to the Ser/Thr phosphatase protein family (27).  The crystal structure 
of Pfu Mre11 has been solved and is shown to be able to bind dsDNA at its dimeric interface 
(28, 29).  The nuclease activity of the MR complex is performed by Mre11.  Mre11 exhibits a 
Mn
2+
-dependent 3’ to 5’ exonuclease activity in vitro which differs from its apparent 5’ to 
3’exonuclease activity in vivo (30). 
 The T4 bacteriophage relies heavily on recombination for DNA replication due to the 
lack of transcription initiation after DNA replication has begun (31).  A majority of the 
proteins involved in T4 phage HR have been characterized and T4 phage has been used as a 
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model system for studying nucleic acid proteins for more than two decades (32).  The T4 
phage homologs of Mre11 and Rad50 (gp47 and gp46, respectively) are required for in vivo 
HR and DSB repair and have not yet been extensively characterized.  Our lab has been able 
to over-express and purify large quantities of T4 phage Mre11 and Rad50 while purification 
of the eukaryotic homologs has proven to be more difficult (30, 33).  As discussed earlier, the 
structures of Pfu Mre11 and Rad50 proteins have been solved individually and, recently, 
structures of the MR complex have been solved for Pfu, Thermatoga maritima, and 
Methanococcus jannaschii (34-37).  Although these studies have provided valuable structural 
information regarding Mre11-Rad50 interaction, nucleotide binding/hydrolysis, and DNA 
binding, the biochemical activity of the MR complex has not been sufficiently characterized.  
The lack of a complete understanding of the T4 phage Mre11 and Rad50, their homology to 
the eukaryotic proteins, and their high expression/simple purification make them an ideal 
system to study.  The desire to gain a deeper understanding of the biochemical characteristics 
of the Mre11-Rad50 complex serves as the basis for this thesis project with an added focus 
on the significance of the Mre11 dimeric interface. 
Thesis Outline 
For my thesis project I examined the T4 Mre11 protein which is involved in the 
processing of DSBs.  I performed initial characterization assays of the wild-type protein and 
also utilized site-directed mutagenesis to generate the L101D-Mre11 mutant.  This mutant 
was designed to alter the dimeric interface of Mre11.  The properties of this mutant have 
proved to be quite interesting and are considerable different than those of wild-type. 
This thesis is setup to show the progress of my research project and contains a 
manuscript published in the Journal of Biological Chemistry and a second manuscript 
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submitted for publication to the same journal.  Chapter II contains the first manuscript which 
discusses the initial biochemical characterization of T4 Mre11 and T4 Rad50.  Chapter III 
contains the second manuscript which investigates the significance of the T4 Mre11 dimer 
interface and how altering the interface affects Mre11-Rad50 complex activity.  Chapter IV 
will be a general conclusion discussing the accomplishments of my research project, future 
directions, and acknowledgements. 
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Figure 1.  Regulation of repair pathway choice. The three modes of DSB repair are outlined. Chemically 
modiﬁed or damaged ends (stars) cannot be repaired by nonhomologous end joining (NHEJ) and require 
processing, whereas free ends can be processed by any pathway. Once initiated, NHEJ inhibits end processing 
via Ku and prevents microhomology-mediated end joining (MMEJ) or homologous recombination (HR). 
Conversely, MRX/N-Sae2/CtIP-dependent resection displaces Ku and inhibits NHEJ. Extensive resection 
results in Rad51 ﬁlament formation and inhibition of MMEJ. NHEJ is used primarily in the G1 phase of the 
cell cycle, and HR is used primarily in the S and G2 phases, following replication of the genome. MMEJ is 
active throughout the cell cycle. Negative interactions are shown by red lines, positive interactions by black 
arrows, and cell cycle transitions by grey arrows. (5). 
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Figure 2. Model for MMEJ and alternative end-joining repair. During the initial stages of MMEJ, Ku70–
Ku80 (green) and Rad51 (red), which inhibit MMEJ, are prevented from binding or are removed. This enables 
50–30 resection by the MRX complex, Sae2 and Exo1 (indicated by dark red partial circle) that reveals 
microhomologous sequences (blue boxes). These microhomologies transiently and dynamically anneal to each 
other. (i) In cases in which the annealing is stable, repair is completed by flap trimming, fill-in DNA synthesis 
and ligation, resulting in a deletion relative to the original sequence. Mismatch repair is not required for MMEJ, 
although it might have a supporting role. (ii) Alternatively, one or more translesion polymerases (yellow) can 
extend the annealed sequences (represented here by orange–blue boxes) using templated error-prone synthesis. 
Dissociation of the initial microhomologies and realignment at other microhomologous sequences, followed by 
flap trimming, fill-in DNA synthesis and ligation completes repair, resulting in a deletion plus insertion event. 
Many variations and iterations of (ii) can hypothetically occur, resulting in complex insertion–deletion 
junctions. (3). 
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Chapter II:  Biochemical Characterization of Bacteriophage T4 Mre11-
Rad50 Complex 
Modified from a paper published in The Journal of Biological Chemistry 
Timothy J. Herdendorf
2
, Dustin W. Albrecht
2
, Stephen J. Benkovic
34
, and Scott W. Nelson
24 
Abstract 
The Mre11/Rad50 complex (MR) from bacteriophage T4 (gp46/47) is involved in the 
processing of DNA double-strand breaks.  Here, we describe the activities of the T4 MR 
complex and its modulation by proteins involved in homologous recombination. T4 Mre11 is 
a Rad50- and Mn
2+
-dependent dsDNA exonuclease and ssDNA endonuclease. ATP 
hydrolysis is required for the removal of multiple nucleotides via dsDNA exonuclease 
activity but not for the removal of the first nucleotide or for ssDNA endonuclease activity, 
indicating ATP hydrolysis is only required for repetitive nucleotide removal.  By itself, 
Rad50 is a relatively inefficient ATPase, but the presence of Mre11 and dsDNA increases 
ATP hydrolysis by 20-fold.  The ATP hydrolysis reaction exhibits positive cooperativity with 
Hill coefficients ranging from 1.4 for Rad50 alone to 2.4 for the Rad50/Mre11/DNA 
complex.  Kinetic assays suggest that approximately four nucleotides are removed per ATP 
hydrolyzed. Directionality assays indicate that the prevailing activity is a 3’to 5’ dsDNA 
exonuclease, which is incompatible with the proposed role of MR in the production of 3’  
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Biology. 
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3
 Department of Chemistry, 414 Wartik Laboratory, The Pennsylvania State University, University Park, 
Pennsylvania, 16802 
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ssDNA ends. Interestingly, we found that in the presence of a recombination mediator 
protein (UvsY) and ssDNA binding protein (gp32), Mre11 is capable of using Mg
2+
 as a 
cofactor for its nuclease activity. Additionally, the Mg
2+
-dependent nuclease activity, 
activated by UvsY and gp32, results in the formation of endonuclease reaction  
products. These results suggest that gp32 and UvsY may alter divalent cation preference and 
facilitate the formation of a 3’ ssDNA overhang, which is a necessary intermediate for 
recombination-mediated double-strand break repair. 
Introduction 
Replication in T4
1
 phage is initiated through origin-dependent and -independent 
pathways (1). The origin-dependent pathway relies on the host cell RNA polymerase to 
synthesize an mRNA transcript, which is then processed and remains stably bound at the 
origin in what is known as an R-loop (2). The origin-independent pathway relies on 
homologous recombination (HR) within or between phage genome(s) (3). HR is essential to 
the lifecycle of T4 phage because the origin-dependent mode of initiation ends after only a 
few rounds of replication (4). A strong link between recombination and DNA repair was 
recognized early on using T4 phage as a model system (reviewed in (5)).  In the late 1960’s it 
was reported that certain genes, when mutated, severely affected replication, recombination, 
and DNA repair (6). Indeed, the current models of DNA double-strand break (DSB) repair 
share many of the same steps as recombination-mediated initiation of replication (7, 8). 
 DSBs are one of the most lethal forms of DNA damage and unless repaired they may 
lead to gross chromosomal rearrangements, deletions, duplications, or cell death (9, 10).  
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DSBs are caused by exogenous agents such as ionizing and ultraviolet radiation and chemical 
mutagens or endogenous agents such as reactive oxygen species.  In eukaryotic cells, DSBs 
are repaired through two pathways, non-homologous end joining (NHEJ) and HR; however, 
in T4 phage it appears that all DSBs are repaired through HR (4, 11). 
 The biochemical activities necessary for HR have been identified and in most cases, 
the proteins responsible for these activities are known (8, 12, 13).  HR begins with the 
processing of a dsDNA end to produce a 3’ ssDNA overhang.  In E. coli, this step is 
performed by the well-characterized helicase/nuclease complex, RecBCD (14). However, the 
genomes of eukaryotes, archaea, and T4 phage do not contain any obvious RecBCD 
orthologs and it appears that the Mre11/Rad50 (MR) complex, together with other proteins 
specific to each system perform the analogous function (15).  Following end resection, the 
recombinase (RecA or RecA ortholog) binds to the ssDNA and forms a nucleoprotein 
filament that is capable of undergoing strand invasion and exchange with homologous DNA 
templates (16). This strand invasion event produces a D-loop structure that acts as a scaffold 
and primer for DNA synthesis (17). The HR pathway ends with either the resolution of the 
Holliday junction by a nuclease or the dissociation and strand annealing of the newly 
synthesized DNA strands (18). 
 In T4 phage, all of the proteins implicated in HR are well characterized except for 
Mre11 and Rad50 (gp47 and gp46, respectively) (19-24). In eukaryotic systems, the MR 
complex has long been associated with the repair of DSBs (25).  In S. cerevisiae, null 
mutants of Mre11, Rad50, or Xrs2 (a third protein found in the S. cerevisiae MR complex) 
are unable to initiate and process meiotic DSBs and are sensitive to DNA damaging agents 
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that produce DSBs such as ionizing  radiation (IR) or methylmethane sulfonate (18). This led 
to a proposal that the MR complex is responsible for resection (5’ to 3’ dsDNA exonuclease 
activity) of DSBs (26).  However, in vitro, the eukaryotic MR complex exhibits a 3’ to 5’ 
dsDNA exonuclease and a ssDNA endonuclease activity (27, 28).  The products of these 
activities are not 3' ssDNA overhangs and therefore the true function of the MR complex has 
been elusive.  
Rad50 is a member of the Structural Maintenance of Chromosome (SMC) family of 
proteins, which are in turn members of the ATP Binding Cassette (ABC) super-family.  All 
known ABC protein family members are dimeric and bind ATP at the interface between two 
monomers.  It is thought that the energy of ATP hydrolysis is used to drive conformational 
changes within the ABC protein/domain, which are then propagated to other associated 
proteins or domains (29).  Most ABC protein family members are membrane transporters, 
such as the CFTR transporter and p-glycoprotein, which cause cystic fibrosis and multi-drug 
resistance, respectively (30).  In addition to transporters, the DNA repair enzymes MutS and 
RecF are ABC proteins.  The structure of the nucleotide binding domain of Pyrococcus 
furiosus (Pfu) Rad50 has been solved in the apo and ATP-bound forms (31).  The structures 
reveal significant conformational rearrangements that occur upon ATP binding and/or 
hydrolysis, which are thought to control the activity of Mre11 (32).  Rad50 and related SMC 
proteins have an unusual architecture where the ABC protein motifs are split by a long 
coiled-coil region.  In Rad50, the apex of the coiled-coil contains a conserved CXXC motif, 
which dimerizes with a second Rad50 monomer to create a zinc binding site similar to a zinc 
finger (33).  The purpose of the coiled-coil motif is not entirely clear, but it is thought to be 
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involved in tethering the DSB to a homologous template or tethering the two ends of the 
DSB to each other (15).  In eukaryotes the coiled-coil domain contains approximately 900 
amino acids, whereas in T4 phage the coiled-coil contains around 200 residues.  Presumably, 
the long coiled-coil region in eukaryotes is responsible for the expression difficulties 
encountered with the eukaryotic proteins.  To date, only microgram quantities of eukaryotic 
Rad50 have been purified (27, 28, 34, 35).   
 Mre11 is a member of the ser/thr protein phosphatase family, which contains four 
conserved motifs and requires divalent cations for activity (36).  Although the mutation of 
Mre11 has only a mild effect in S. cerevisiae (37), in human cells the nuclease activity of 
Mre11 is essential and its inactivation results in embryonic lethality and extreme sensitivity 
to IR (38).  In humans, inherited Mre11 mutations cause ataxia telangiectasia-like disorder, 
the symptoms of which include hypersensitivity to IR and cerebellar degeneration (39).  The 
Pfu Mre11 protein is dimeric and binds dsDNA near the dimeric interface (40).  As 
mentioned above, in vitro assays reveal that Mre11 possesses a 3’ to 5 dsDNA exonuclease 
activity, along with a ssDNA endonuclease activity (27).   
 Recently, several papers have clarified the role of the MR complex in the processing 
of DSBs.  The Symington and Ira labs simultaneously demonstrated that DSBs are processed 
through a two-step mechanism involving the MR complex, Sae2, ExoI, Sgs1, and Dna2 (41, 
42).  In the initial step, the MRX complex, in conjunction with Sae2, remove approximately 
100-200 bases from the 5' end of the DNA.  In the second step, ExoI or Sgs1 with Dna2 
catalyze rapid and processive removal of thousands of bases from the 5' end of the DNA.  
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The resulting 3' ssDNA overhang can undergo Rad51-dependent HR or Rad52-dependent 
single-strand annealing. 
 In this report, we express, purify, and biochemically characterize the MR DNA repair 
complex from T4 phage.  We find that the T4 MR complex shares all the same activities as 
its eukaryotic counterparts, but expression and purification of the Rad50 and Mre11 proteins 
is rapid and yields milligram quantities of purified proteins, which allows for the mechanistic 
examination of the complex.  Our experiments indicate that the T4 MR complex is a DNA-
activated ATPase, a Mn
2+
-dependent ssDNA endonuclease and a Mn
2+
- and ATP-dependent 
3’ to 5’ dsDNA exonuclease.  ATP hydrolysis is positively cooperative with respect to ATP 
concentration and during the exonuclease reaction four nucleotides are removed per ATP 
hydrolyzed.     While the observed 3’ to 5’ dsDNA exonuclease activity is incompatible with 
its proposed in vivo function, we find that the presence of two T4 recombination proteins, 
UvsY and gp32, alter the nuclease activity of the MR complex, which may promote the 
formation of a 3’ ssDNA recombinogenic end.                  
Experimental Procedures 
Cloning, Expression, and Purification of T4 Mre11 and wt-Rad50 and K42M-Rad50 - The 
open reading frames for gp46 and 47 were PCR amplified from bacteriophage T4 genomic 
DNA (Sigma-Aldrich) and cloned into the pTYB1 expression vector (NEB) using the NdeI 
and SapI restriction sites using the following primers: T4Rad50-NdeF: 5'- 
GGTGGTCATATGAAGAATTTTAAACTTAATAG; T4Rad50-SapR: 5'- 
GGTGGTTGCTCTTCCGCATTAAACCATTACAGTAAATCG; T4Mre11-NdeF: 5'- 
GGTGGTCATATGAAAATTTTAAATTTAGGTG; and T4Mre11-SapR  5'- 
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GGTGGTTGCTCTTCCGCATCATTGTGTTGCCTCTACATATAG.  The K42M-Rad50 
mutant was generated using the QuickChange™ protocol (Stratagene) using the following 
mutagenic forward primer: K42M-Rad50F:  5’-
GGACGAAATGGCGGTGGTATGTCTACTATGCTAGAAGCC-3’, where the mutant 
codon is highlighted in bold-face.  The reverse mutagenic primer is the reverse-complement 
of the forward.  The pTYB1 vector creates a fusion between the gene of interest and a self-
cleavable Intein/Chitin binding domain purification tag.  The gp46-pTYB1, K42M-gp46-
pTYB1, and gp47-pTYB1 expression vectors were separately transformed into BL21(DE3) 
cells and plated on LB-agar plates containing 150 µg/ml ampicillin.  A single colony from 
each plate was used to separately inoculate 50 ml flasks of LB-amp that was shaken for 16 
hours at 37
o
C.  10 ml of starter culture was used to inoculate four, 1 liter flasks of LB-AMP 
per protein, which were shaken at 225 rpm at 37
o
C to an OD600 of 0.8.  The flasks were then 
cooled to 18
o
C and expression was induced by the addition of 0.2 mM IPTG.  After 16 hours 
the cells were collected by centrifugation at 8000 g for 8 minutes and pellets were frozen at -
20
o
C. 
 The purification scheme for T4 Rad50 (including K42M-Rad50) and Mre11 are 
identical through the chitin column elution step.  A frozen cell pellet (approximately 15 g) 
was resuspended in 75 ml of ice-cold lysis buffer (20 mM Tris-HCl, 500 mM NaCl, 1 mM 
EDTA, pH 8.0) and lysed by sonication.  All purification steps were carried out at 4
o
C.  The 
lysed cells were then centrifuged at 18000g for 60 minutes.  The cell-free extract was loaded 
onto a column packed with 5 ml of chitin beads (New England Biolabs).  The column was 
then washed with 100 ml of lysis buffer followed by an overnight wash with 1.5 L of wash 
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buffer (20 mM Tris-HCl, 1M NaCl, 1 mM EDTA, pH 8.0).  Cleavage of the Intein-CBD tag 
was initiated by washing the column with 3 column volumes of cleavage buffer (20 mM 
Tris-HCl, 200 mM NaCl, 1 mM EDTA, 75 mM βME, pH 8.0) prior to stopping the buffer 
flow.  The chitin column was incubated in cleavage buffer for 16 hours at 4
o
C, followed by 
elution of the tag-less protein.  Mre11 was dialyzed twice against 1 L of storage buffer (20 
mM Tris-HCl, 200 mM NaCl, 20% glycerol, pH 8.0), concentrated to 50-100 µM, dispensed 
into small aliquots, and frozen at -80
o
C.  Rad50 was loaded directly onto a 20 ml cellulose 
phosphate (P11, Whatman) column, followed by a 10-column volume wash with P11 wash 
buffer (20 mM Tris-HCl, 200 mM NaCl, pH 8.0).  T4 Rad50 was eluted from the P11 
column with P11 elution buffer (20 mM Tris-HCl, 400 mM NaCl, 20% glycerol, pH 8.0), 
concentrated to 25-50 µM, dispensed into aliquots, and frozen at -80
o
C.   The extinction 
coefficients for determining the concentration of T4 Mre11 and Rad50 are 69,130 cm
-1
M
-1
 
and 33,140 cm
-1
M
-1
, respectively. 
DNA Substrates - The M13 phage ssDNA was purified using PEG precipitation and 
phenol/chloroform extraction (43).  The 50 bp dsDNA substrate was prepared by annealing 
equal amounts of two complementary oligonucleotides with the following sequences: 
ds50mer_top, 5'- CTC TTG GTG ATT ATG ATG GTT GCA ATA CAT TTA ATT TCA 
TTA TCA ATT AG-3' and ds50mer_bottom, 5'- CTA ATT GAT AAT GAA ATT AAA 
TGT ATT GCA ACC ATC ATA ATC ACC AAG AG-3'.  The 17 position 2-aminopurine 
(2-AP) containing substrate was of identical sequence to ds50mer_top except that the adenine 
at positions 17 (relative to the 3’ end of the DNA) was replaced with 2-AP.  The DNA 
substrate with the 2-AP at the 1 position (3’ end) had an identical sequence to ds50mer_top 
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except that the 3’ G was replaced with 2-AP.  To prepare the 5’-labeled 50 bp DNA, the 
annealed duplex was diluted to a concentration of 5 μM and treated with polynucleotide 
kinase (NEB) and 10 μCi of [γ-32P] ATP in a volume of 20 μL (total ATP concentration of 
0.165 μM) for 30 minutes.  After 30 minutes cold ATP was added to a final concentration of 
100 μM and allowed to react for 30 additional minutes.  The reaction was then quenched at 
65
o
C for 20 minutes, followed by removal of free nucleotides by passing the reaction through 
a G-25 Sephadex spin column.  To prepare the 3’-labeled 50 bp DNA, the annealed duplex 
was diluted to a concentration of 10 µM and treated with 5 units of T4 DNA polymerase 
(Promega) in the presence of 1 mM dCTP, dTTP, and dATP in a final volume of 20 µL for 5 
minutes.  The reaction was then heated at 65
o
C for 20 minutes to inactivate the T4 
polymerase.   Following heat inactivation, 5 units of T4 exonuclease-deficient polymerase 
was added to the reaction, along with 20 μCi of [α-32P] dGTP, in a final volume of 38 µL.  
The reaction was allowed to proceed at 37
o
C for 30 minutes prior to the addition of 2 µL of 
0.1 mM dGTP.  The reaction was continued for 30 additional minutes, then heat inactivated 
for 20 minutes at 65
o
C.  Finally, the reaction was passed through a G-25 Sephadex spin 
column to remove free nucleotides and precipitated protein.  The uniformly labeled 1.68 kb 
dsDNA was prepared by performing a 100 μL PCR reaction in Taq polymerase buffer 
(Promega) using 5 units of Taq polymerase, 40 μCi of [α-32P] dGTP, 0.1 mM cold dNTP 
mix,  1 μM gp46-Nde-F, 1 μM gp46-Sap-R, and 100 ng of the gp46-pTYB1 vector.  The 
labeled PCR product was purified using Qiagen’s PCR purification kit following the 
manufacturer’s protocol and quantitated using liquid scintillation counting.    
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Nuclease and ATP Hydrolysis Assays - The standard conditions for the nuclease reactions 
were 20 mM Tris-HCl, 50 mM KCl, 2 mM ATP, pH 7.6 and a divalent metal concentration 
indicated in the figure legends.  The concentrations of ssDNA, dsDNA, Rad50, and Mre11 
varied for each experiment and are given in the individual figure legends.  The gp32 and 
UvsY proteins were purified by intein/chitin-based affinity chromatography as described 
(44).  Reactions that were analyzed using 1% TAE-agarose gels (Figure 1) were quenched in 
5 mM Tris-HCl, pH 7.5, 200 mM EDTA, 0.2% orange G, 0.015% bromophenol blue, 
0.015% xylene cyanol FF, and 7.5% Ficoll 400.  The agarose gels were stained with 10 
μg/ml ethidium bromide for 30 minutes prior to visualization.  Reactions that were analyzed 
using TBE-Urea-PAGE (15% polyacrylamide) (Figures. 2 and 7) were quenched with 50 
mM EDTA, 95 % formamide, 0.015% xylene cyanol FF, and 0.015% bromophenol blue.  
The PAGE gels were ran for 2 hours at 35 mA, followed by overnight exposure to a 
phosphorimager plate and subsequent analysis using a Storm phosphorimager and 
ImageQuant software (GE Life Sciences).  The reactions that were analyzed using PEI-TLC 
(Figures 4C, 4D, 5A, and 6) were quenched in an equal volume of 200 mM EDTA.  The 
quenched samples were then spotted onto the PEI plates (1-2 μL volume) and developed in 
300 mM KPi, pH 7.0.  The TLC plate was then dried and exposed for 2 hours to the 
phosphorimager plate followed by analysis using the Storm phosphorimager and ImageQuant 
software.   
 To examine the steady-state exonuclease activity of the MR complex, we employed a 
real-time continuous assay based on the enhancement of fluorescence when the nucleotide 
analog, 2-AP is excised from DNA (45).  The assay was carried out at 30
o
C using excitation 
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and emission wavelengths of 310 and 375 nm, respectively, on a Cary Eclipse (Varian) 
spectrofluorometer.  The reaction buffer contained 50 mM Tris-HCl (pH 7.6), 50 mM KCl, 5 
mM MgCl2, 0.3 mM MnCl2, 0.1 µM MR complex, and 1.3 µM 2-AP labeled dsDNA.  The 
reactions were monitored for approximately 5-10 minutes and velocities were determined 
using at least 3 minutes of the time course.   
 To determine the steady-state ATP hydrolysis activity of Rad50 and the MR complex, 
we employed the standard coupled fluorometric ATP hydrolysis assay (46) carried out at 
30
o
C using excitation and emission wavelengths of 340 and 460 nm, respectively, on either a 
SLM-Aminco (SLM Instruments, Inc.) or a Cary Eclipse spectrofluorometer (Varian).  The 
reaction buffer contained 50 mM Tris-HCl (pH 7.6), 50 mM KCl, 5 mM MgCl2, 50 µM 
NADH, 150 µM phosphoenolpyruvate, 6.67 Units/ml of pyruvate kinase and 10 Units/ml of 
lactate dehydrogenase.  In reactions where Mre11 was included, its concentration was always 
in slight excess over the Rad50 concentration.  In reactions containing DNA, its 
concentration was held in excess over that of Rad50 or the MR complex and well above the 
Kactivation for DNA (Herdendorf and Nelson, unpublished).  Steady-state rate constants were 
determined using Sigmaplot 10.0/Enzyme Kinetics Module 1.3 (Systat Software, Inc.).       
Results 
Expression and Purification of T4 Rad50 and Mre11 - Over-expression of eukaryotic Mre11 
and Rad50 requires the use of either S. cerevisiae or insect cells and yields only microgram 
amounts of purified protein (27, 28, 34).  Moreover, eukaryotic Rad50 is difficult to over-
express separately and requires co-expression of Mre11 to form significant amounts of 
soluble protein (47).  We have achieved over-expression and purification of T4 Rad50 by 
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constructing a C-terminal fusion with the Intein/CBD domain provided by the pTYB1 vector.  
The CBD domain facilitates capture by chitin beads and the intein domain allows for 
reductant-mediated self cleavage (48).  Following self-cleavage, the protein that elutes from 
the chitin beads contains a strong absorbance at 260 nm, indicating the presence of bound 
nucleotides or nucleic acids.  Dialysis of the protein did not reduce the 260 nm absorbance, 
therefore we applied the eluted protein to phosphocellulose resin.  The material that strongly 
absorbed at 260 nm was not retained by the column but nearly 100% of the protein was 
efficiently bound.  Following a buffer wash, the NaCl concentration was increased from 200 
to 400 mM, which eluted the Rad50 protein.  This protein had a 280/260 nm ratio of 1.98, 
indicating that there is little to no nucleotide or nucleic acid contamination in our preparation 
of Rad50.  Additionally, no appreciable enhancement of DAPI dye fluorescence was 
observed upon addition of protease-K digested Rad50, indicating the absence of 
contaminating DNA (data not shown).  The overall yield for T4 Rad50 was ~3 mg protein 
per liter of LB (Fig. 1A, lane 3).  The Rad50 Walker A motif mutant, K42M-Rad50, behaved 
essentially identical to the wild-type protein.     
    T4 Mre11 was also C-terminally fused to the intein/CBD domain provided by the 
pTYB1 vector.  Mre11 was expressed in an identical fashion as Rad50 but was 
approximately 10-fold more abundant in the cell-free extracts as compared to Rad50.  
Additionally, no appreciable 280/260 nm absorbance ratio indicated that no nucleotides or 
nucleic acids were present in the protein that eluted from the chitin column.  Therefore, only 
a single-column was necessary to achieve the desired level of purity.  The overall yield for 
T4 Mre11 was ~25 mg protein per liter of LB (Fig. 1A, lane 2).   
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Requirements for Mre11 Nuclease Activity - To determine the requirements for the predicted 
Mre11 nuclease activity, we performed agarose gel electrophoresis-based nuclease assays.  
The metal, protein, and ATP dependence was tested using circular ssDNA (M13mp18) and 
linear dsDNA (Fig. 1B).  The ssDNA nuclease reaction required the presence of Mre11, 
MnCl2, and Rad50.  Under these conditions, replacement of MnCl2 with MgCl2 or ZnCl2 
resulted in no observable nuclease activity (data not shown).  The dsDNA nuclease reaction 
required the same components; however, ATP was also necessary for nucleolytic degradation 
of the dsDNA.  In addition to defining the components required for nuclease activity, these 
results strongly argue against the presence of a contaminating nuclease in our preparations of 
either Mre11 or Rad50 (since both proteins are required).  We next tested the endo/exo 
activity using linear and circular ssDNA or dsDNA (Fig. 1C).  These reactions indicate that 
the T4 MR complex contains a ssDNA endonuclease activity (i.e., both linear and circular 
ssDNA are degraded) and a dsDNA exonuclease activity (i.e., only linear dsDNA is 
degraded).  We also confirmed that the nuclease activity resides in the Mre11 subunit (Fig. 
1D).  This assignment is predicted based on sequence analysis; however, the nuclease subunit 
of the T4 MR complex had been previously assigned to Rad50 rather than Mre11 (49).  We 
separately assayed the ability of Mre11 and Rad50 to degrade dsDNA at elevated 
concentrations of protein in the presence of MnCl2 and ATP (Fig. 1D).  Although the activity 
is >100-fold less than the MR complex, as expected, the nuclease activity resides within the 
Mre11 subunit.   
Polarity of the dsDNA Exonuclease Activity of the MR complex - To determine the nuclease 
polarity of the MR complex, we compared the product pattern resulting from nuclease 
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activity using either 5' or 3' labeled 50 bp dsDNA (Fig. 2). The presence of intermediate 
length products in reactions using the 5' labeled DNA substrate and their absence in reactions 
with the 3’ labeled DNA substrate is consistent with a 3’ to 5’ exonuclease. 
Steady-state ATP Hydrolysis Activity of Rad50 and the MR complex – Rad50 is part of the 
ABC protein super-family and it is known that Rad50 catalyzes the hydrolysis of ATP (50).  
Additionally, the data shown in figure 1 indicates that ATP is necessary for the dsDNA 
exonuclease activity of the MR complex.  For these reasons, we examined the Mg-ATP 
hydrolysis activity of the MR under conditions where the nuclease activity is negligible (i.e., 
in the absence of Mn
2+
).  We determined the steady-state Mg-ATP hydrolysis rate constants 
for Rad50 and the MR complex with and without DNA (Table II).  Since these reactions are 
performed without Mn
2+
, DNA is not consumed and can be considered an activator rather 
than a substrate.  We found that by itself, Rad50 is a relatively weak ATPase and the rate of 
ATP hydrolysis is sigmoidally dependent on the concentration of ATP.   The data fit best to 
the Hill equation: 
   
         
        
                                                (eq. 1) 
where v is velocity, Vmax is the maximal velocity at saturating substrate concentration, Km is 
the Michaelis constant (substrate concentration where v = 0.5·Vmax), and n is the Hill 
coefficient.  An F-test was employed to justify the use of the Hill equation over the standard 
Michaelis-Menton equation.  The data fitting yielded a kcat of 0.15 sec
-1
, a Km of 16 µM, and 
a Hill coefficient of 1.4.  Addition of Mre11 results in minor changes in the kinetic constants 
with 1.5- and 2.6-fold  increases in the kcat (0.226 sec
-1
) and Km (41.5 µM), respectively, and 
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no significant change in the Hill coefficient (1.5).  Addition of dsDNA to Rad50 alone 
caused a 3.4-fold increase in Km (54 µM) and very minor decreases in kcat (0.10 sec
-1
) and 
Hill coefficient (1.2).  Addition of DNA to the MR complex caused a 14-fold increase in the 
kcat relative to the MR complex alone (3.2 sec
-1
), an increase in Hill coefficient (2.4), and no 
significant change in the Km (49.2 µM).  The large activation of ATPase activity is specific to 
linear dsDNA as circular plasmid DNA or a 50 base ssDNA oligonucleotide had no effect 
(data not shown).  Mutation of the predicted Walker A lysine to methionine (K42M-Rad50) 
reduced the observed ATPase activity ~200-fold compared to Rad50 alone and ~4000-fold 
compared to the MR/DNA complex.  This large decrease in activity is expected given the 
role the Walker A lysine plays in stabilizing negative charge that forms during the transition 
state for ATP hydrolysis.  The residual activity that is observed represents the upper-limit for 
the level of ATPase contamination in our preparation of Rad50 (less than 0.025%).         
Steady-state Exonuclease Activity of the MR Complex  - To continuously monitor the 
exonuclease activity of the MR complex, we employed the fluorescent nucleotide analog, 2-
AP, which has low fluorescence when incorporated into DNA and high fluorescence as a free 
nucleotide.  We performed the assay under steady-state conditions ([DNA]>[enzyme]) with 
the 2-AP probe located at either the 1 or 17 position relative to the 3’ end of a 50 bp DNA 
substrate.  As seen in Fig. 3A, when the 2-AP probe is located at the 1 position, the steady-
state exonuclease activity of both the wild-type and K42M-Rad50 MR complex is essentially 
unaffected by the presence of either ATP or the non-hydrolyzable ATP analog, AMP-PNP 
(kcat’s ranging between 2.3 and 3.2 min
-1
).  When the 2-AP probe is located at the 17 position 
(Fig. 3B), the steady-state exonuclease rate of both wild-type and the K42M-Rad50 MR 
26 
 
 
complex is much reduced compared to the 1 position substrate with kcat’s of 0.03 min
-1
 and 
0.015 min
-1
, respectively.  Addition of ATP to the wild-type MR complex increases the 
exonuclease rate (0.24 min
-1
) but decreases the rate of the K42M-Rad50 MR complex (0.008 
min
-1
).  The addition of AMP-PNP decreases the rate of both the wild-type and K42M-Rad50 
MR complex with kcat’s of 0.001 min
-1
 and 0.006 min
-1
, respectively.     
Metal Dependence of ATP Hydrolysis and Exonuclease Activities – Even though the nuclease 
activity strongly prefers MnCl2 over MgCl2, the ATP hydrolysis activity of the MR/DNA 
complex prefers MgCl2 (Fig. 4A).  Under steady-state conditions, the apparent kcat for ATP 
hydrolysis in the presence of 5 mM MgCl2 or 5 mM MnCl2, is 2.8 ± 0.3 and 0.23 ± 0.03 sec
-
1
, respectively.  Since the nuclease activity requires MnCl2, yet under physiological 
conditions the concentrations of Mg
2+
 far exceeds that of Mn
2+
 (51), we measured the rate of 
ATP hydrolysis at fixed MgCl2 (5 mM) while varying the concentration of MnCl2 from 0.1 to 
5 mM (Fig. 4B). The ATP hydrolysis rate is inhibited by MnCl2 with an IC50 of 1.3 ± 0.1 
mM.  We next explored the metal dependence of the nuclease reaction in more detail.  We 
employed the uniformly [α-32P] dGTP labeled 1.6 kb PCR product  as the exonuclease 
substrate and again varied the concentration of MnCl2 in the presence of 5 mM MgCl2 (Fig. 
4C).  The nuclease activity sharply increased between MnCl2 concentrations of 0 mM and 0.1 
mM, followed by a slow decrease in nuclease activity between 0.4 mM and 5 mM.  This data 
can be fit using the following uncompetitive substrate inhibition equation: 
  
        
          
   
  
 
                                         (eq. 2) 
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where v is velocity, Vmax is the maximal velocity at saturating activator concentration, Ka is 
the Michaelis constant for the activator (concentration of A where v = 0.5·Vmax), and Ki is 
the inhibition constant.  The data fitting yielded a Ka-Mn
2+
 of 0.011 ± 0.002 mM and Ki-
Mn
2+
 of 4.1 ± 0.8 mM.  Finally, we compared the MR complex’s nuclease activity with 5 
mM MnCl2 alone or with 5 mM MgCl2 and 0.3 mM MnCl2 in combination (Fig. 4D). The 
results of this assay indicate that the nuclease activity is essentially identical under both of 
these conditions.   
Rad50 ATP Hydrolysis and Utilization During the Exonuclease Reaction- A TLC-based 
assay was employed to simultaneously monitor the ATP hydrolysis and exonuclease activity 
of Rad50 and Mre11, respectively, using MgCl2 and MnCl2 concentrations of 5 and 0.3 mM, 
respectively (Fig. 5A). To visualize both DNA and ATP, we used a uniformly [α-32P] dGTP 
labeled 1.6 kb PCR product as the DNA substrate and ATP that was labeled at the γ 
phosphate with 
32
P.  The concentration of ATP was held at 0.2 mM, which is approximately 
4-fold above the Km-ATP for the MR complex (Table II).  The TLC assay enables 
visualization of both ATP/ADP and DNA/dGMP, making the determination of ATP 
utilization highly accurate.  The MR complex was held in excess over the DNA substrate so 
that the rate of exonuclease activity reflects the rate of nucleotide excision and translocation 
and not productive DNA binding. As seen in Fig. 5B, the rate of exonuclease and ATPase 
activity is 0.1664 μM/sec-1 and 0.0408 μM/sec-1, respectively.  This suggests that 
approximately four bases are removed for every ATP hydrolyzed.  The concentration of 
dsDNA ends in this assay is 0.0217 μM, which represents the upper limit for the 
concentration of DNA-bound MR complex.  Assuming a fully saturated dsDNA substrate 
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during the exonuclease reaction, the kcat for ATP hydrolysis is then 1.9 sec
-1
 and the 
maximum rate of nucleotide removal is 7.67 sec
-1
. 
The Effect of T4 UvsY and gp32 Proteins on the Exonuclease Activity of the MR Complex – 
Consistent with MR complexes from human, P. furiosus, and S. cerevisiae, Mn
2+
 is the 
preferred metal for the exonuclease reaction in the T4 system.  However, because 
physiological concentrations of Mg
2+
 far exceed those of Mn
2+
 (51), we further explored the 
ability of Mg
2+
 to support exonuclease activity.  To quantify the exonuclease activity of the 
MR complex with Mg
2+
 and Mn
2+
 we employed the uniformly [α-32P] dGTP labeled 1.6 kb 
PCR product and the TLC assay (Fig. 6).  Protein was held in excess over the dsDNA 
substrate, therefore the loss of product can be fitted to a single-exponential decay with rate 
constants of 0.105 ± 0.001 min
-1
 and 0.009 ± 0.0005 min
-1
 for Mn
2+
 and Mg
2+
, respectively 
(an 11-fold difference between Mn
2+
 and Mg
2+
).  We then tested the effect of UvsY and gp32 
on the exonuclease rates in the presence of either Mg
2+
 or Mn
2+
.  UvsY and gp32 were 
chosen as possible candidates for the modulation of MR complex activity because these two 
proteins bind to the product of the MR reaction (i.e., ssDNA) and participate in the 
subsequent step of DSB repair (strand invasion).  We found that the presence of UvsY and 
gp32 increased the Mg
2+
-dependent reaction by nearly 5-fold (rate constant of 0.0410 ± 
0.0037 min
-1
) while having no effect on the rate of the Mn
2+
-dependent reaction (rate 
constant of 0.1031 ± 0.0104 min
-1
).  Separately, UvsY and gp32 had no measurable effect on 
the Mg
2+
-dependent nuclease activity (data not shown).   Several control experiments were 
performed to rule out the possibility of nuclease contamination in our preparations of UvsY 
and gp32 (Fig. 6). The Mg
2+
-dependent exonuclease reaction required Rad50, Mre11, UvsY, 
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gp32, and ATP.  Omission of Rad50, Mre11, or ATP resulted in a complete loss of the 
exonuclease activity, strongly arguing against the introduction of a contaminating nuclease 
present in the preparations of UvsY or gp32.  We also examined the effect of UvsY and gp32 
on the steady-state rate of ATP hydrolysis by the MR complex in the presence of a DNA 
substrate (Table II).  Separately, UvsY and gp32 did not significantly alter the rate, whereas 
the combination reduced the rate by 1.9 fold. 
     The polarity of the UvsY/gp32-enhanced, Mg
2+
-dependent exonuclease reaction, 
was examined under steady-state conditions using 3’ labeled 50 bp dsDNA.  This substrate 
was chosen since the appearance of any DNA products of intermediate size represents a 
deviation from the strict 3’ to 5’ exonuclease reaction that was observed in Fig. 2.  Under 
steady-state conditions (which are required when short DNA substrates are used), the Mg
2+
-
dependent reaction in the absence of UvsY/gp32 is nearly undetectable (i.e., the UvsY/gp32 
enhancement of the steady-state Mg
2+
-dependent reaction appears greater than the 5-fold 
observed in Fig. 6).  Therefore, we compared the Mn
2+
-dependent reaction to the Mg
2+
-
dependent reaction, both in the presence of UvsY/gp32.    As shown in Fig.  7, in contrast to 
the reaction in the presence of Mn
2+
, the Mg
2+
-dependent reaction results in products with a 
length ranging between 15 and 25 bases, suggesting that an additional form of nuclease 
activity has occurred.  Quantitation of this reaction reveals that approximately 32% of the 
products were between 15 and 25 bases with the remaining 68% as dGMP.       
 Discussion 
 Bacteriophage T4 is a well established model system for investigating the 
biochemistry of proteins involved in DNA replication, recombination, and repair (3, 52, 53).   
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Studies using the T4 phage model system led to the first proposed model for recombination-
dependent DNA replication (RDR) (54).  The RDR model begins with the formation of a 
single-stranded 3’ DNA end that subsequently undergoes strand invasion and pairing with a 
homologous dsDNA template.  The single-stranded 3’ DNA can be formed as a result of 
incomplete replication of the lagging strand or through the action of a nuclease.  Over the 
past three decades since the RDR model was proposed, all of the enzymes and proteins that 
are required to carry out RDR in T4 have been isolated and extensively characterized 
biochemically, with the notable exception of the nuclease complex thought to be responsible 
for the creation of the 3’ ssDNA overhangs [Rad50 (gp46) and Mre11 (gp47)].  Here we 
have described, for the first time, the expression, purification, and biochemical 
characterization of the Rad50 and Mre11 proteins from bacteriophage T4.   
 On a qualitative level it appears that the various activities of the MR complex are well 
conserved between all three kingdoms of life.  The T4 MR complex is an ATPase, a ssDNA 
endonuclease, and a 3’ to 5’ dsDNA exonuclease.  ATP hydrolysis is positively cooperative 
and is activated by the presence of Mre11 and DNA.  We have found that during repetitive 
dsDNA exonuclease activity, approximately 4 nucleotides are removed for every ATP that is 
hydrolyzed and the maximum exonuclease rate is 7.7 bases/sec.  ATP hydrolysis increases 
the rate of multiple nucleotide excisions but does not alter the rate of the first nucleotide 
excision.     Interestingly, we have found that two T4 phage proteins that are necessary for the 
subsequent steps of RDR/DSB repair activate the Mg
2+
-dependent nuclease reaction, which 
produces an altered product profile as compared to the Mn
2+
-dependent exonuclease reaction. 
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 To our knowledge, this is the first instance that the steady-state ATP hydrolysis rate 
constants have been reported for a Rad50 homolog in the presence and absence of Mre11 and 
a DNA substrate.  We found that by itself, Rad50 is a relatively inefficient ATPase with a kcat 
of 0.15 sec
-1
.  The reaction is mildly positively cooperative with a Hill coefficient of 1.4, 
indicating Rad50 is a least a dimer, consistent with the structural analysis of Pfu Rad50 and 
other ABC proteins (31, 32).  Separately, the addition of DNA or Mre11 to Rad50 resulted in 
very minor perturbations in the kinetic parameters of Rad50.  In contrast, the addition of both 
Mre11 and DNA resulted in a 20-fold increase in kcat and an increase in the Hill coefficient to 
2.4.  These reactions are performed with Mg
2+
 as the only divalent cation so that there is 
essentially no nuclease activity under these conditions.  This indicates that ATP hydrolysis 
can be uncoupled from nuclease activity and suggests that Mre11 and dsDNA act as 
allosteric activators of Rad50.  The increase in the Hill coefficient from 1.4 to 2.4 suggests 
that in the presence of Mre11 and dsDNA, there are more than two ATP sites in 
communication with each other.  It is not clear how this might occur, but it is tempting to 
speculate that binding of dsDNA promotes hetero-octamer (Mre112/Rad502)2 formation 
through zinc-hook mediated tethering of Rad50’s coiled-coil domains (15).  Hetero-octamers 
of the Pfu MR complex have been previously observed in electron microscopy (33) and 
atomic force microscopy experiments (55) have revealed that DNA binding results in a 
straightening of Rad50’s coiled-coils, which prevents an intracomplex tether (hetero-
tetramer) and promotes an intercomplex tether (hetero-octamer).         
 The exact function of Rad50’s ATP hydrolysis activity has been unclear (56).  Based 
on structural changes between the ATP-free and bound forms of Pfu Rad50, it has been 
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proposed that ATP hydrolysis induces a conformational change that may promote product 
release (dNMP) or drive MR complex translocation (31).  Our data are inconsistent with the 
product release model, since the rate of excision of the first nucleotide at the 3’ end of the 
DNA is not affected by ATP.  Additionally, the stoichiometry of ATP hydrolysis is one ATP 
per four nucleotides removed.  If ATP hydrolysis was directly linked to product release, then 
a 1:1 correspondence between ATP hydrolysis and nucleotide removal would be expected.  
The data are more consistent with ATP being involved in the translocation of the MR 
complex following nucleotide excision and release.  Since ATP and AMP-PNP do not affect 
the rate of the first nucleotide excision for either the wild-type or K42M-Rad50 MR 
complexes, it is unlikely that the MR complex must unwind or open the DNA duplex prior to 
nucleotide excision.  In contrast, ATP hydrolysis increased the exonuclease rate when the 
probe is moved 17 bases away from the 3’ end, indicating that ATP hydrolysis is necessary 
for multiple, processive nucleotide excisions.  This suggests that the energy of ATP 
hydrolysis is likely driving translocation of the MR complex.  Consistent with this, when the 
probe is in the 17 position, AMP-PNP potently inhibits the exonuclease activity of the wild-
type enzyme and both ATP and AMP-PNP inhibit the K42M-Rad50 MR complex.  The 
observed inhibition is likely due to the stalling of the MR complex following nucleotide 
excision and product release (i.e, the MR complex is unable to translocate or dissociate from 
the DNA in the ATP-bound form).  In the absence of ATP, the MR complex likely 
dissociates from the DNA substrate and rebinds at the new ss/dsDNA junction (non-
processively).  If this interpretation is correct, then the steady-state exonuclease rate constant 
in the presence of AMP-PNP is equal to the rate of dissociation of the MR complex from 
DNA.  The 1:4 ATP/base stoichiometry suggests that the Mre11 is able to remove four 
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nucleotides before it is required to translocate to the new ss/dsDNA junction.  This would 
require “scrunching” of the DNA, similar to that which has been proposed for the NS3 
helicase (57).   
 The data shown in Figure 2 are consistent with a 3’ to 5’ dsDNA exonuclease.  This 
activity is at odds with the proposed physiological function of the MR complex, a paradox 
that has been long recognized (15, 58, 59).  It is conceivable that the observed 3’ to 5’ 
exonuclease activity is the relevant physiological activity and the MR complex does not 
directly participate in the production of a 3’ ssDNA overhangs.  However, this possibility 
seems unlikely for the following reasons: 1)  it is well established that in eukaryotes the 
nuclease activity of the MR complex is required for the removal of Spo11/Rec12, which is 
covalently linked to the 5’ end of the DSB during meiosis (60); 2) the nuclease activity of 
Mre11 is required for the removal of topoisomerase-5’ DNA covalent adducts that are 
stabilized by anti-cancer etoposide derivatives (10); 3) the nuclease activity of Mre11 is 
required for repair of IR-induced DSBs (38); and 4) in T4 phage, Mre11 and Rad50 are 
necessary for the initiation of recombination dependent replication and recombination-
dependent DSB repair, which begins with the 5’ to 3’ resection of a DNA end (7, 61).  Even 
with the above data, the precise role of the MR complex in DSB repair is still an open 
question and the polarity paradox remains.  Therefore, we tested several T4 recombination 
proteins for a possible change in the nuclease mechanism of the T4 MR complex.  In the 
presence of MnCl2, we did not observe any significant differences in the rate or product 
profile of MR nuclease assays in the presence of UvsX, gp32, and UvsY, either alone or in 
combination.  However, UvsY and gp32 were found to enhance the ability of the T4 MR 
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complex to utilize MgCl2 as a cofactor for the nuclease activity.  We examined the product 
profile of the MgCl2-dependent reaction in the presence of UvsY and gp32 and in addition to 
the dGMP that is produced by 3’ to 5’ exonuclease activity, we also observed a distribution 
of products in the size range of 15 to 25 bases.  These products could be the result of a 5’ to 
3’ exonuclease or an endonuclease activity.  We favor an endonuclease mechanism due to the 
absence of products between 50 and 25 bases, which would be produced if 5’ to 3’ 
exonuclease activity had occurred.  Experiments are currently underway to determine the 
exact nature of the alteration in nuclease mechanism.  A metal-dependent change nuclease 
mechanism has also been observed in the MR complex from the thermophilic organism P. 
furiosus when assayed at elevated (physiologically relevant) temperatures (59).  In the case 
of the Pfu MR complex, the MgCl2-dependent reaction produces a 3’ ssDNA overhang 
through endonucleolytic cleavage of sites close to the 5’ end of the dsDNA, similar to what 
we are proposing here for the T4 MR complex.   
 The mechanism behind the increased ability to use Mg
2+
 as a cofactor is not clear but 
likely involves physical interaction(s) between the MR complex and UvsY/gp32.  Based on 
our observation that 5 mM MgCl2 does not inhibit the nuclease activity of the complex, even 
when the concentration of MnCl2 is 50-fold lower (0.1 mM), it appears that the affinity of 
Mg
2+
 for the Mre11 active site is low compared to Mn
2+
.  This is consistent with the fact that 
Mre11 crystals grown in the presence of MgCl2 only have one of the two required divalent 
cation sites occupied (62).  If this is correct and Mre11 normally has weak affinity for MgCl2, 
then it is plausible to assume that UvsY and gp32 act in an allosteric manner to increase the 
affinity of Mg
2+
 for the active site of Mre11.  This hypothesis requires that gp32 and/or UvsY 
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directly interact with the MR complex, which has been previously observed in T4 phage 
lysate (63).  Additionally, in vivo experiments have strongly suggested a physical interaction 
between gp32 and the MR complex (64).  To enhance the affinity of Mg
2+
 for Mre11, the 
interaction of gp32 and/or UvsY with the MR complex would have to reorient the active site 
in some manner.  The nature of this putative active site perturbation is unclear and may 
require crystallographic analysis of the T4 MR complex.   
 The mechanism behind the Mg
2+
-dependent change in product profile is also not clear 
and will require further investigation.  One hypothesis is that the ssDNA endonuclease 
activity of the MR complex is enhanced in the presence of Mg
2+
 and UvsY/gp32.  This 
requires at least transient melting of the DNA duplex, which is an activity that has been 
previously observed in gp32 (65, 66).  If gp32 and/or UvsY were to also protect the 3’ but 
not the 5’ strand of the DNA from endonucleolytic cleavage, then this would result in the 
production of a 3’ ssDNA overhang that is pre-bound with UvsY and gp32 and primed for 
the next step of recombination, filament formation by UvsX.  It is clear from the data shown 
in Figure 7 that even the presence of UvsY and gp32, there is still a high level of 3’ to 5’ 
dsDNA exonuclease activity (nearly 70% of the products are produced as a result of 
exonuclease activity).  This may indicate that additional proteins are required for the efficient 
production of a 3’ ssDNA overhang.  Based on recent results from S. cerevisiae and P. 
furiousis, which demonstrated the involvement of helicases in MR-dependent DSB resection 
(42, 59), a possible candidate is UvsW helicase.  UvsW helicase is known to be necessary for 
DSB repair (67, 68) and is a functional analog of Sgs1, which is the S. cerevisiae helicase 
involved in DSB resection.  We are currently in the process of testing the above hypothesis.         
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  With the biochemical characterization of the bacteriophage T4 MR complex reported 
here, the entire complement of T4 phage proteins involved in recombination and DSB repair 
have been purified and assayed in vitro.  The bacteriophage T4 system provides milligram 
quantities of purified Mre11 and Rad50, which is not currently possible in the eukaryotic 
systems.    Given the apparent conservation in DNA repair mechanisms between all 
kingdoms of life, it is expected that the T4 phage model system will provide valuable 
mechanistic insights into what has been termed the “keystone complex” of DNA repair (69). 
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1
The abbreviations used are: T4 phage, bacteriophage T4; DSB, double-strand break; 
HR, homologous recombination; gp46, T4 gene product 46; gp47, T4 gene product 47; gp32, 
T4 gene product 32; UvsY, UV sensitivity protein Y; MR, Mre11/Rad50; SMC, structural 
maintenance of chromosomes; ABC, ATP binding cassette; ssDNA, single-stranded DNA; 
dsDNA, double-stranded DNA; Pfu, Pyrococcus furiosus  
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Table I 
 
Steady-State Kinetic Constants for BacteriophageT4 Rad50 ATP Hydrolysis 
Protein  kcat (s
-1
) Km (µM) Hill (n) 
Rad50
a
 0.146 ± 0.003  16.0 ± 0.8  1.4 ± 0.1  
Rad50/DNA
b
 0.100 ± 0.003 54.1 ± 0.6 1.2 ± 0.1 
Mre11/Rad50
c
 0.226 ± 0.006  41.5 ± 0.3  1.5 ± 0.1  
Mre11/Rad50/DNA
d
 3.2 ± 0.1  49.2 ± 1.6  2.4 ± 0.2  
 
a
Concentrations were as follows: 0.5 µM Rad50. 
b
Concentrations were as follows: 0.5 µM Rad50, 2 µM DNA. 
c
Concentrations were as follows: 0.5 µM Rad50, 0.63 µM Mre11. 
d
Concentrations were as follows: 0.08 and 0.3 µM Rad50, 0.13 and 0.5 µM Mre11, 0.33 and 
1 µM DNA. 
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Table II 
 
The Effect of UvsY and gp32 (T4 SSB) on ATPase Activity of the Mre11/Rad50  
 
Protein Complex
a
 kcat (s
-1
)
b
 
Mre11/Rad50/DNA 3.2±0.1 
Mre11/Rad50/DNA/UvsY 2.5±0.4 
Mre11/Rad50/DNA/gp32 2.9±0.2 
Mre11/Rad50/DNA/UvsY/gp32 1.7±0.1 
 
a
Concentrations were as follows: Mre11, 83 nM; Rad50, 67 nM; DNA, 1 µM; UvsY, 550 
nM; and gp32, 524 nM.   
b
Apparent kcat (rate measured at saturating concentrations of ATP and DNA).  The values 
reported are the average of three individual measurements.  Errors represent the standard 
deviation. 
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Figure 1.   A) SDS-PAGE analysis of purified bacteriophage T4 Mre11 and Rad50.  Approximately 20 µg of 
protein was separated using 12% SDS-PAGE and stained with Coomassie blue R-250.  Lanes 1-3 are molecular 
weight markers, Mre11, and Rad50, respectively.  B) The requirement for nuclease activity using circular 
ssDNA (0.4 µg) and linear dsDNA (0.4 µg) as substrates.  The concentrations of MnCl2 (Mn), Mre11 (M), 
Rad50 (R), and ATP were 5 mM, 0.3 µM, 0.3 µM, and 2 mM, respectively.  The reaction was performed at 
37
o
C for 30 minutes.  The products of the reaction were analyzed using TAE-agarose gel electrophoresis and 
stained with ethidium bromide.  C) Nuclease reactions using circular and linearized forms of ss and dsDNA (0.4 
µg each) using MnCl2, Rad50 (R), Mre11 (M), and ATP concentrations of 5 mM, 0.3 µM, 0.3 µM, and 2 mM, 
respectively.  D) Nuclease assay carried out for 60 minutes using dsDNA (0.4 µg), 5 mM MnCl2, 2 mM ATP, 
and the indicated concentrations of either Mre11 or Rad50. 
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Figure 2.  Polarity of T4 Mre11/Rad50 dsDNA exonuclease activity.  A)  Analysis of nuclease reaction 
products using 16% UREA-PAGE.  The reaction was carried out at 37
o
C and the time points for each lane are 0, 
0.5, 1, 2, 4, and 8 minutes.  The concentrations of dsDNA, Mre11, Rad50, MnCl2, and ATP were 0.5 µM, 0.1 
µM, 0.1 µM, 5 mM, and 2 mM, respectively.  The dGMP band was identified by comparison to a reaction 
analyzed using PEI-TLC. 
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Figure 3.  Steady-state exonuclease activity of wild-type and mutant MR complexes.  A) Exonuclease 
activity using the 50 bp dsDNA substrate with the 2-AP probe located at the 3’ end of the DNA.  The 
concentrations of DNA, Mre11, Rad50 (wild-type and K42M), ATP, and AMP-PNP were 1.3 µM, 0.105 µM, 
0.1 µM, 0.25 mM, and 0.25 mM, respectively.  The black and grey bars represent the wild-type and K42M-
Rad50 MR complexes, respectively. B) Exonuclease activity using the 50 bp dsDNA substrate with the 2-AP 
probe located at position 17 relative to the 3’ end of the DNA.  The concentrations of DNA, Mre11, Rad50 
(wild-type and K42M), ATP, and AMP-PNP were 1.3 µM, 0.42 µM, 0.4 µM, 0.25 mM and 0.25 mM, 
respectively.   The black and grey bars represent the wild-type and K42M-Rad50 MR complexes, respectively.  
The numbers above the low-activity conditions represent kcat (min
-1
).  The error bars for both A and B represent 
the standard deviation of at least three assays.     
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Figure 4.  The dependence of Mg
2+
/Mn
2+
 cation on ATP hydrolysis and dsDNA exonuclease activity.    A) 
The rates of ATP hydrolysis in the presence of 5 mM MgCl2 or MnCl2.  The rates were determined using the 
coupled fluorometric assay as described in “Materials and Methods” using Rad50, Mre11, and DNA 
concentrations of 50 nM, 67 nM, and 260 nM, respectively.  B)  The effect of increasing MnCl2 concentration 
on the rate of ATP hydrolysis in the presence of 5 mM MgCl2.  The concentrations of Rad50, Mre11, and 
dsDNA are identical to panel A.  C)  Quantification of a PEI-TLC exonuclease assay using the uniformly 
labeled 1.68 kb dsDNA using a fixed concentration of MgCl2 (5 mM) and increasing concentrations of MnCl2.  
The concentrations of Rad50, Mre11, and ATP were 0.5 µM, 0.5 µM, and 2 mM, respectively.  Each reaction 
was carried out for 10 minutes using a dsDNA concentration of 0.024 µM.  D)  Time course of exonuclease 
activity at 5 mM MnCl2 (closed diamonds) or 0.3 mM MnCl2 and 5 mM MgCl2 (closed squares) using the 
uniformly labeled 1.68 kb dsDNA (6 nM) and identical protein and ATP concentrations as panel C.      
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Figure 5.  Kinetics of the Mre11/Rad50 dsDNA exonuclease reaction.  A) An exonuclease reaction time 
course analyzed via PEI-TLC.  The substrates (DNA and ATP) and products (ADP and dGMP) can be 
simultaneously monitored.  The reactions were performed at 37
o
C containing Rad50 (0.5 µM), Mre11 (0.5 µM), 
ATP (2 mM), MgCl2 (5 mM), MnCl2 (0.3 mM), and 1.68 kb DNA (.024 µM).  B) Quantification of the PEI-
TLC plate shown in A).  The closed diamonds represent the exonuclease reaction product (dGMP) and the 
closed squares represent the ATP hydrolysis product (ADP).   
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Figure 6.  The effect of UvsY and gp32 on the MgCl2-dependent exonuclease reaction.  Quantification of a 
PEI-TLC exonuclease assay using the uniformly labeled 1.68 kb dsDNA.  Reactions contained Rad50 (0.5 µM), 
Mre11 (0.5 µM), UvsY (1 µM, hexamer), gp32 (1 µM), ATP (2 mM), and either MgCl2 or MnCl2 (5 mM).   The 
conditions are: MnCl2, Mre11, Rad50, and ATP (closed squares); MgCl2, Mre11, Rad50, and ATP (closed 
diamonds);  MnCl2, Mre11, Rad50, UvsY, gp32, and ATP  (closed circles); MgCl2, Mre11, Rad50, UvsY, gp32, 
and ATP  (closed triangles); MgCl2, UvsY, gp32, and ATP (open squares); MgCl2, Mre11, Rad50, UvsY, gp32, 
and ATP omission (open circles). 
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Figure 7.  Comparison of nuclease products in reactions containing UvsY and gp32 with MgCl2 and MnCl2.  A) 
Analysis of nuclease reaction products using 16% UREA-PAGE.  The time points for both reactions are 0, 0.5, 1, 2, 
4, and 8 minutes.  The concentrations of the Mre11, Rad50, and ATP for the MgCl2 (5 mM) containing reaction were 
0.1 µM, 0.1 µM. and 2 mM, respectively.  The concentrations of the Mre11, Rad50, and ATP for the MnCl2 (5 mM) 
containing reaction were 0.025 µM, 0.025 µM, and 2 mM, respectively.  The concentrations of UvsY, gp32, and the 
3’-
32
P labeled 50 bp dsDNA for both reactions were 1 µM, 1 µM, and 0.5 µM, respectively.  The inset highlights the 
portion of the gel corresponding to a mobility between 25 and 15 bases.  B) The size distribution of the products 
contained in lane 4 of the Mg
2+
-dependent reaction (black) and lane 6 of the Mn
2+
 dependent reaction (light grey).  
These lanes are indicated by asterisks at the top of the gel.  The nearly overlapping traces at the 50 base positions 
indicate that the reaction has proceeded to the same extent. 
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Chapter III:  Disruption of Bacteriophage T4 Mre11 Dimer Interface 
Reveals Two-State Mechanism for Exonuclease Activity 
Modified from a paper submitted to The Journal of Biological Chemistry 
Dustin W. Albrecht
2
, Timothy J. Herdendorf
2
, and Scott W. Nelson
23 
Abstract 
The Mre11/Rad50 (MR) complex is a central player in DNA repair and is implicated 
in the processing of DNA ends caused by double strand breaks.   Recent crystal structures of 
the MR complex suggest that several conformational rearrangements occur during its ATP 
hydrolysis cycle.  A comparison of the Mre11 dimer interface from recent x-ray crystal 
structures suggests that the interface is dynamic in nature and may adopt several different 
arrangements.  In order to probe the functional significance of the Mre11 dimer interface, we 
have generated and characterized a dimer disruption Mre11 mutant (L101D-Mre11).  
Although L101D-Mre11 binds to Rad50 and dsDNA with affinity comparable to the wild-
type enzyme, it does not activate the ATP hydrolysis activity of Rad50, suggesting that the 
allosteric communication between Mre11 and Rad50 has been interrupted.  Additionally, the 
dsDNA exonuclease activity of the L101D-MR complex has been reduced by 10-fold under 
conditions where processive exonuclease activity is required.  However, we unexpectedly 
found that under steady state conditions, the nuclease activity of the L101D-MR complex is 
5-fold greater than that of the wild-type complex.  Based on steady state and single-turnover 
 1 This research has been submitted to The Journal of Biological Chemistry for publication. 
2
 Department of Biochemistry, Biophysics, and Molecular Biology, Iowa State University, Ames, Iowa 50011 
3
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 nuclease assays, we have assigned the rate-determining step of the steady state nuclease 
reaction to be the productive assembly of the complex at the dsDNA end.  Together, our data 
suggest that the Mre11 dimer interface adopts at least two different states during the 
exonuclease reaction. 
Introduction 
Double-strand breaks (DSB)
1
 are among the most harmful forms of DNA damage, 
and they may lead to deletions, duplications, or cell death if they go unrepaired (1).  DSBs 
are common and can result from both internal and external causes.  External causes include 
ultraviolet radiation, ionizing radiation (IR), and genotoxic chemicals.  Internal causes 
include reactive oxygen species and protein complexes that interfere with replication fork 
progression.  DSBs are also deliberately formed during the development of antibodies 
through VDJ recombination (2). 
The three pathways for repairing DSBs in eukaryotic cells have been described in the 
literature:  homologous recombination (HR), non-homologous end-joining, and 
microhomology-mediated end-joining (3).  Mre11 and Rad50 form a heterotetrameric 
complex (Mre112/Rad502, referred to as the MR complex hereafter) that is involved in all 
three of the above mentioned DSB repair pathways (3, 4).  The role of the MR complex is 
best understood in HR, which involves several steps and requires multiple proteins (5).  The 
MR complex is involved in the initial step of HR, which is the resection of the 5’ strand of 
the DSB to create 3’ single-stranded DNA.  The role of the MR complex in this process has 
been recently elucidated using the Saccharomyces cerevisiae model system (6–8).  Resection 
is a two-step process in eukaryotes with the MR complex being essential for the first step.  In 
the first step of S. cerevisiae cells, the MR complex works along with Xrs2 and Sae2 to 
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remove 50-100 nucleotides (nts) from the 5’ end of the DSB (6).  In the second step, the 
intermediates created by the MR complex are further resected (>500 nts) by Sgs1/Top3/RmiI 
and RPA or ExoI and RPA.  Upon completion of DSB resection, Rad51 promotes strand 
invasion of the ssDNA into a region of homologous DNA and creates a D-loop that is used as 
a primer for DNA synthesis (9).  Upon completion of DNA synthesis, either the extended 
strand is liberated from the template by a DNA helicase, or the Holliday junction is resolved 
by a DNA nuclease and ligase (10). 
The MR complex is present in eukaryotes, archaea, prokaryotes, and some 
bacteriophage biological systems (4).  While the MR complex homologs from eukaryotes, 
archaea, and bacteriophage participate in DSB resection, the prokaryotic MR homolog, the 
SbcCD complex, does not seem to be involved in DSB resection, instead prokaryotic 
resection is carried out by the RecBCD helicase/nuclease complex (11).  The T4 
bacteriophage homologs of the MR complex (gp46/gp47) are required for in vivo 
homologous recombination and DSB repair and T4 bacteriophage has been used as a model 
system for the investigation of nucleic acid enzymes for many years (12–14). 
Rad50 belongs to the structural maintenance of chromosomes protein family, which is 
a subset of the ATP binding cassette (ABC) protein superfamily (15, 16).  The ABC 
superfamily of proteins is broadly distributed and contains a well-conserved dimeric 
nucleotide binding domain (NBD) that binds and hydrolyzes ATP at its dimeric interface 
(17).  The energy obtained from ATP hydrolysis is used by ABC proteins to promote a 
variety of biological functions (17).  T4 Rad50 (gp46) is an inefficient ATPase (kcat of 0.15 s
-
1
), but becomes much more active (kcat of 3.2 s
-1
) upon the addition of Mre11 and double-
stranded DNA (dsDNA) (18).  Although it does not affect the initial rate of nucleotide 
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removal, ATP hydrolysis increases the rate of repetitive nucleotide removal leading to the 
hypothesis that ATP hydrolysis is involved in MR complex translocation along the DNA 
substrate (18, 19). 
 Mre11 is a member of the Ser/Thr protein phosphatase superfamily, which requires 
divalent cations for their catalytic activity (20).  In vitro assays have shown that T4 Mre11 
(gp47) contains the nuclease subunit of the MR complex and has single-stranded DNA 
(ssDNA) endonuclease, dsDNA exonuclease, and a probable end-dependent dsDNA 
endonuclease activity (18).    Knockout of Mre11 in S. cerevisiae causes only mild effects, 
but has a much more profound impact in humans (21, 22).  Mre11 deficiency in humans can 
lead to ataxia telangiectasia-like disorder, which causes IR sensitivity and cerebellar 
dysfunction (23). 
 Several recent crystal structures have greatly clarified the architecture of the 
heterotetrameric MR complex.  A combination of small angle x-ray scattering and x-ray 
crystallography using full-length Mre11 and Rad50 with the majority of its coiled-coil and all 
of the zinc-hook removed revealed that the M2R2 heterotetramer can exist in at least two 
different conformations, termed open and closed (24–28).  In the open conformation, the 
nucleotide binding domains (NBDs) of Rad50 are far away from each other with Mre11 
acting as a bridge holding the heterotetramer together (24).  In the presence of ATP or an 
ATP analog, the Rad50 nucleotide binding domains come together and form the classic 
sandwich dimer that has been observed in many ABC proteins.  A surprising feature of these 
new structures has been the relative position of Mre11 with respect to the coiled-coil domain 
of Rad50.  Instead of being placed between the coiled-coils of Rad50 as it has been 
traditionally depicted in schematic models, Mre11 embraces Rad50 on the surface of Rad50 
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opposing the coiled-coil domain (27, 28).  As a consequence of this arrangement, the 
nuclease active sites of Mre11 are somewhat protected by Rad50 so that it appears difficult 
for anything larger than ssDNA to approach the Mre11 active site.  Hopfner and colleagues 
have identified at least four separate Mre11-Rad50 interfaces that contribute to stabilizing the 
MR complex heterotetramer (27).  The most extensive interface is formed through a C-
terminal helix-loop-helix of Mre11 that interacts with the base of the coiled-coil domain of 
Rad50.   Also interacting with the base of the coiled-coil of Rad50 is the linker domain that 
separates the HLH and Cap domains of Mre11.  The remaining interfaces are formed through 
interactions between the Mre11 cap and phosphoesterase domains and the nucleotide binding 
domain of Rad50.  Any or all of these domains may be involved in allosteric signal 
transmission between Mre11 and Rad50.  Besides the four heterosubunit interfaces, there are 
three additional homosubunit interfaces, two from the Rad50 dimer and one from the Mre11 
dimer.  The most extensive homosubunit interface is that of the NBD of Rad50, which is 
typical of all ABC proteins and has been readily observed in many x-ray crystal structures 
(15).  The second Rad50-Rad50 interface is the zinc-hook, which is found at the apex of the 
coiled-coil domain (29).  This interface is defined by a shared Zn
2+
 binding site that is 
formed through a tetrathiolate linkage where each coiled-coil provides two cysteine residues.  
While this type of binding site generally binds Zn
2+
 with extremely high affinity and is 
therefore thought to be extremely stable, atomic force microscopy experiments suggest that 
the Rad50 zinc-hook domain is dynamic and able to respond to DNA binding by Rad50 (30).  
The Mre11-Mre11 homodimeric interface is relatively small, made up of a four-helix bundle 
with two helices being provided by each subunit (Fig. 1 and Fig 2A).  The interaction 
between these helices is largely hydrophobic with the exception of two salt bridges.  X-ray 
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crystal structures and protein cross-linking indicate that the Mre11 dimeric interface 
undergoes small conformation rearrangements upon ATP binding by Rad50 (24, 27).                                       
 To explore the significance of the Mre11 dimeric interface, we utilized site-directed 
mutagenesis on T4 Mre11.  A hydrophobic residue (Leu
101
) located in the Mre11 dimeric 
interface was chosen and mutated.  In an effort to determine the significance of the dimer 
interface, we investigated the effects of the mutation on the MR complex in terms of Rad50 
and DNA affinity, activation of Rad50 ATP hydrolysis activity, and nuclease activity.  Our 
assays show that disruption of the Mre11 dimeric interface has no effect on the affinity of 
Mre11 for Rad50.  Also, the disrupted dimeric interface appears to have little effect on MR 
complex DNA binding and ssDNA endonuclease activity.  However, the disruption has 
profound effects on the ATPase activity of Rad50 and the exonuclease activity of Mre11 in 
both steady state and pre-steady state assays. 
Experimental Procedures 
Mutagenesis, Protein Expression, and Purification– The L101D-Mre11 mutant was 
constructed using the Stratagene QuikChange site-directed mutagenesis protocol.  The 
presence of the mutation and the integrity of the entire open reading frame were verified 
using DNA sequencing.  Bacterial expression and purification of the L101D-Mre11, wild-
type Mre11 (WT-Mre11) and Rad50 proteins were carried out as previously described 
(18)(31). 
Circular Dichroism (CD) Spectroscopy− CD studies on WT- and L101D-Mre11 were 
performed at 22
o
C on a Jasco J710 CD spectrometer in a 1-cm cell using a protein 
concentration of approximately 0.25 mg/ml. The buffer used was 10 mM Tris-HCl, 200 mM 
NaCl, pH 7.6.  Spectra were collected from 200 to 260 nm in increments of 0.2 nm. Each 
55 
 
 
spectrum was blank-corrected and L101D-Mre11 was normalized to the ellipticity of the WT 
protein at 210 nm to correct for differences in protein concentration.    
ATP Hydrolysis Assays – Determinations of Km, kcat, and level of DNA activation were 
performed as previously described (18). 
Competition by L101D-Mre11 with WT-Mre11 for Rad50– The relative affinity of the 
L101D-Mre11 mutant for Rad50 was determined using a coupled ATPase assay (32).  All 
assays were done at 30° C.  The reaction was performed in a buffer containing 50 mM Tris-
HCl, 50 mM KCl, 5 mM MgCl2, 0.1 mg/ml BSA (referred to hereafter as ‘standard buffer’) 
with 1 mM ATP, 1 µM DNA, 300 µM NADH, 2 mM phosphoenolpyruvate, 6 units/ml 
pyruvate kinase, and 10 units/ml lactate dehydrogenase  at pH 7.6 in a volume of 125 µL.  
The sequence of the oligonucleotides used to create the DNA substrate were the following,  
ds50-F:  5'-
CTCTTGGTGATTATGATGGTTGCAATACATTTAATTTCATTATCAATAAG-3', 
ds50-R: 5'-
CTTATTGATAATGAAATTAAATGTATTGCAACCATCATAATCACCAAGAG-3'.  The 
oligonucleotides were dissolved in sterile water, quantitated by measuring the absorbance at 
260 nm mixed in equal molar ratios, and annealed by heating to 80°C for 5 minutes and 
slowly cooled to room temperature.   In each assay, WT-Mre11 and Rad50 each had a 
concentration of 0.1 µM while the L101D-Mre11 concentration had values of 0, 0.05, 0.1, 
0.2, 0.4, 0.7, and 1.0 µM in each respective assay.  ATP hydrolysis was assayed 
spectrophotometrically on a Varian Cary 50 UV-Vis spectrophotometer by monitoring 
absorbance at 340 nm.  All assays were started with addition of the preassembled WT-MR 
complex. 
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Nuclease Assays– The ssDNA endonuclease activity was monitored using single-strand 
circular M13 DNA as a substrate (1 µg per lane).  The reactions were carried out in standard 
buffer with 0.3 mM MnCl2.  Mre11 and Rad50 concentrations were held at 0.3 µM.  At the 
indicated time points, 10 µL of reaction was removed and quenched with EDTA.  Each time 
point was then run out on a 1% TAE-agarose gel containing ethidium bromide and visualized 
using UV light.  
The steady state product profile of the MR complex was visualized using denaturing 
polyacrylamide gel electrophoresis (PAGE).  All assays were done at 30° C in standard 
buffer with 0.3 mM MnCl2 in the presence of 1.3 µM hexachlorofluorescein (HEX) labeled 
DNA substrate.  The HEX label was attached to the 5’ end of the ds50-F primer and a 
phosphorothioate linkage was introduced between the 1
st
 and 2
nd
 nucleotides of the ds50-R 
substrate (relative to the 3’ end).   The phosphorothioate linkage prevented Mre11 from 
excising nucleotides from the unlabeled DNA strand.  The Mre11 and Rad50 concentrations 
varied and are denoted in each individual figure legend.  Reactions that used an ATP 
regeneration system contained 1 mM ATP, 7 mM phosphocreatine, and 2 units of creatine 
kinase.  The reactions were started by addition of the DNA substrate (containing ATP and 
MnCl2) to an equal volume of the protein solution.  At times 0, 5, 10, 15, 20, 30, 40, 50, 60, 
70, 80, 90, 100, 110, and 120 minutes a 12 µL aliquot was removed and quenched with an 
equal volume of quench buffer containing 50% formamide and 100 mM EDTA.  The zero 
time point was taken prior to the initiation of the reaction by sequentially adding an aliquot of 
the protein solution and an aliquot of the DNA solution to the quench buffer.  Reaction 
products were resolved with 16% denaturing PAGE containing 7.5 M urea in 1X TBE buffer.  
Gels were run for 3 – 3.5 h at a constant power of 60 W.  The gel was visualized on a 
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Typhoon Phosphorimager using a 532 nm laser and a 555 nm bandpass filter and analyzed 
using the ImageJ software (NIH). 
The pre-steady state exonuclease assays were performed as described for the steady 
state assays with some exceptions.  The DNA substrate was identical, except that a biotin 
group was attached to the 3’ end of the ds50-R DNA strand.  The reactions included a two-
fold molar excess of streptavidin (tetramer) relative to DNA concentration in order to 
completely block the nuclease activity of Mre11 on the unlabeled DNA strand under high 
enzyme concentrations.  The concentrations of DNA, Rad50, and Mre11 were 100 nM, 3 
µM, and 3.15 µM, respectively.  ATP concentrations used were 5 x the Km-ATP for each 
protein and no ATP regeneration system was used.  Time points for the assays were 0, 3, 5, 
7, 10, 15, 20, 25, 30, 40, 50, 60, 80, 100, and 120 seconds. 
The uniformly labeled 1.96 kb dsDNA used in the exonuclease reaction shown in Fig. 
2D was prepared by performing a 100 µL PCR reaction in Long Amp polymerase buffer 
using 5 units of Long -
32
P] dGTP, 0.25 mM cold dNTP mix, 1 
µM T7 promoter primer, 1 µM T7 terminator primer, and 50 ng of the gp46-pET28a vector.  
The labeled PCR product was purified using the Qiagen PCR purification protocol.  Three 
more PCR react -
32
P] dGTP.  
They were subject to the same PCR cycle and purification protocols and quantitated using 
their A260 -
32
P] 
dGTP labeled product.  The exonuclease reaction was performed in the standard buffer with 
0.3 mM MnCl2, 7mM phosphocreatine, and 2 units/20 µL of creatine kinase at pH 7.6.  
-
32
P] dGTP labeled 1.96 kb 
dsDNA.  The ATP concentration was kept at 5 x the Km-ATP for each protein.  Mre11 and 
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Rad50 were at concentrations of 1.25 µM and 1.0 µM, respectively.  The assays were started 
by addition of the DNA substrate to the protein solution.  The assays were quenched by 
adding 2 µL of the assay to an equal volume of 250 mM EDTA. Time points of 0, 1, 2, 4, 8, 
16, and 32 minutes were taken for both the WT- and L101D-MR complex.  The zero time 
point was taken prior to the initiation of the reaction by sequentially adding an aliquot of the 
protein solution and an aliquot of the DNA solution to the quench buffer.  The reactions were 
analyzed by spotting 2 µL onto Baker-flex cellulose PEI-F TLC plates and developed in 300 
mM KPi pH 7.0.  The TLC plates were dried, then exposed for 2 hours to a PhosporImager 
plate.  After exposure, the plate was visualized on a Typhoon Phosphorimager and analyzed 
on the ImageJ software. 
2-Aminopurine Assays – Nuclease activity was also probed spectrofluorometrically using 
DNA substrates with a fluorescent 2-aminopurine  deoxyribonucleotide (2-AP) at either the 
1
st
, 2
nd
, 5
th
, 9
th
, 12
th
, 17
th
, or 22
nd
 position relative to the 3’ end of the substrate.  The assays 
were performed in the standard buffer with 0.3 mM MnCl2 and 1.3 µM DNA substrate.  In 
assays containing ATP, the ATP concentration was 5 x the Km-ATP for each protein.  Steady 
state exonuclease assays were performed at 30° C, pH 7.6, in a volume of 300 µL.  The 
concentration of the MR complex was held at 400 nM.  An MR concentration of 100 nM was 
used in the assays probing the 1
st
 and 2
nd
 positions in the presence of ATP.  An MR 
concentration of 50 nM was used in the L101D-MR complex assay probing the 1
st
 position in 
the absence of ATP.  Mre11 was always held in slight excess over Rad50 (1.05:1 ratio, 
Mre11:Rad50).  The 2-AP was excited at a wavelength of 310 nm and the increase in 
fluorescence was monitored at 375 nm on a Varian Cary Eclipse spectrofluorometer.  Pre-
steady state assays were performed using a Bio-logic SFM-400 stopped flow apparatus held 
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at 30
o
C in the standard assay buffer with 0.3 mM MnCl2.  In assays containing WT-MR 
complex, the ATP, DNA, and protein concentrations were 1 mM, 200 nM, and 3 µM, 
respectively.  In assays containing the L101D-MR complex, the ATP, DNA, and protein 
concentrations were 1 mM, 200 nM, and 2 µM, respectively.  The nucleotide, DNA, and 
protein were held in separate syringes and simultaneously injected into the flow cell at time 
zero.    
DNA Binding Assays –The DNA binding affinity of the MR complex was determined using a 
fluorescence polarization assay carried out with a Synergy 2 Multi-Mode microplate reader.  
All assays were done at ambient temperature in the standard buffer with 10 nM 
hexachlorofluorescein labeled DNA substrate.  Mre11 and Rad50 concentrations used were 
12 µM followed by a series of ten two-fold serial dilutions and a zero protein condition.  In 
the MR complex assays, Mre11 was always held in slight excess over Rad50 (1.05:1 ratio, 
Mre11:Rad50).  The ATP concentration was kept at 5 x the Km-ATP for each protein.  The 
reactions were started by the sequential addition of the protein and the DNA substrate 
(containing ATP, when applicable) to a well in a black 96-well microplate.  The total volume 
for each individual well was 100 µL.  Samples were excited at 520 nM and polarization data 
was collected at 560 nM.  Data was analyzed and Kd values were determined using 
SigmaPlot. 
Oligomeric Determination of the T4 Mre11/Rad50 Complex – Oligomeric determination was 
carried out as previously described with the exception that 200 mM NaCl was used in the 
buffer instead of 50 mM NaCl (18). 
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Results 
Rationale for the L101D mutation–The T4 homology model generated with the Swiss-model 
server (33) using the structure of the Pyrococcus furiosus Mre11 (PDBid 3DSC) indicated 
that Leu
101
 is the T4 phage amino acid corresponding to residue Leu
97
 from P. furiosus, 
which when mutated has been shown to disrupt dimerization (34).  Although it is possible 
that the T4 homology model may not be entirely accurate, it is highly likely that the 
prediction for the core T4 Mre11 structure is correct.  To date, the published Mre11 
structures from a prokaryote (Thermotoga maritima), two eukaryotes (human and 
Schizosaccharomyces. pombe) and two archaea (P. furiosus and Methanococcus jannaschii) 
all share a very similar core catalytic domain (28, 34–37).  The dimeric interface of the 
prokaryotic and archaea Mre11 structures vary somewhat with respect to the orientation of 
the monomeric subunits, but the residues that make up the hydrophobic interface are highly 
conserved (37).  The equivalent residue in S. pombe Mre11 (Ile
148
) is part of the hydrophobic 
interface as well (35).  However, the human Mre11 dimer interface is somewhat different, 
with the equivalent residue (Leu
143
) being part of the interface helix, but not spanning the 
interface.  Instead, it may be involved in an interaction with an adjacent helix in the same 
subunit (36).  Despite these differences, we can conclude with some degree of confidence 
that Leu
101
 resides in or at least very near the T4 phage Mre11 dimeric interface.  We 
expected that introduction of a negatively charged side chain into this interface would 
destabilize this region and therefore test the role of this interface in the overall functioning of 
the MR complex.   
Steady state ATP hydrolysis Activity –The addition of WT-Mre11 and dsDNA to Rad50 
results in a 22-fold increase in kcat-ATP, a 3-fold increase in Km-ATP, and an ATP 
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cooperativity increase (i.e., Hill coefficient) from 1.4 to 2.4 (18).  These parameters were 
determined for the L101D-MR complex to determine the effect of disrupting the dimeric 
interface on the allosteric activation of Rad50 (Table 1).  The kcat-ATP of the L101D-MR-
DNA complex was 10-fold lower than that of the WT-MR-DNA complex, whereas the Km-
ATP and ATP cooperativity was effectively unchanged.  In the absence of dsDNA, the kcat-
ATP of the L101D-MR complex was nearly normal, indicating that the binding of L101D-
Mre11 to Rad50 does not negatively affect the conformation of Rad50 in the absence of 
dsDNA.  Consistent with this, the CD spectrum of L101D-Mre11 was essentially identical to 
that of the WT enzyme (supplemental Fig. S1).   
DNA Binding – To determine the relative affinities of WT- and L101D-MR complexes for 
dsDNA and ssDNA, we employed a fluorescent polarization assay using either dsDNA or 
ssDNA with a single 5’ hexachlorofluorescein label.  As seen in Table 2, Rad50 by itself 
binds dsDNA with relatively high affinity and is unaffected by the presence of ATP (Kd 
values of 0.14 and 0.22 µM in the absence and presence of ATP, respectively).  Neither WT- 
nor L101D-Mre11 displays measurable dsDNA binding at concentrations up to 12 µM.  
Surprisingly, when either WT- or L101D-Mre11 was added to Rad50 in the absence of ATP, 
the resulting MR complex had weaker affinity for both dsDNA and ssDNA as compared to 
Rad50 by itself (Kd values of 0.69 and 0.62 µM for the WT- and L101D-MR complex, 
respectively).  However, upon addition of ATP, tight binding is restored (Kd values of 0.15 
and 0.13 µM for the WT- and L101D-MR complex, respectively).  The affinity of Rad50 for 
ssDNA is nearly identical to that of dsDNA (Kd values of 0.16 and 0.26 µM in the absence 
and presence of ATP, respectively).  Also, similar to what is observed with dsDNA, both the 
WT- and L101D-MR complex have lower affinity for ssDNA as compared to Rad50 alone 
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(Kd values of 0.62 and 0.96 µM for the WT- and L101D-MR complex, respectively).  
However, unlike dsDNA binding, the inclusion of ATP does not greatly affect the affinity of 
the MR complex for ssDNA (Kd values of 0.48 and 0.39 µM for the WT- and L101D-MR 
complex, respectively) 
Competition by L101D-Mre11 with WT-Mre11for Rad50 – To compare the affinity of WT-
Mre11 and L101D-Mre11 for Rad50 a spectrophotometric ATPase assay was utilized.  In the 
assay, WT-Mre11 and Rad50 were both held at a concentration of 0.1 µM and DNA was 
saturating at 1 µM.  The concentration of L101D-Mre11 was varied between 0 and 1.0 µM.  
The relatively low kcat-ATP of the L101D-MR complex compared to the WT-MR complex 
made this a suitable assay (i.e., formation of the L101D-MR complex will result in a lower 
activity compared to the WT-MR complex).  The apparent kcat-ATP (i.e., a specific activity 
determination at saturating concentrations of ATP and DNA) was determined and plotted for 
each condition (Fig. 2B).  As seen in Fig. 2B, L101D-Mre11 successfully out-competed WT-
Mre11, with a calculated IC50 of 0.11 ± 0.01 µM, which indicates equal affinity since the 
concentration of WT-Mre11 was 0.1 µM. 
Oligomeric Determination of the T4 Mre11/Rad50 Complex – We previously determined that 
the T4 WT-MR complex is a heterotetramer (Mre112/Rad502) in solution using 
sedimentation equilibrium analytical ultracentrifugation (AUC) (31).  Here, we again used 
AUC to determine the oligomeric state of WT-Mre11, L101D-Mre11, and the L101D-MR 
complex.  Due to the instability of Rad50 alone during the prolonged AUC run (~96 hours), 
we are unfortunately unable to determine its oligomeric state in the absence of bound Mre11.  
The determined molecular weights are provided in Table 3.  We found that both WT- and 
L101D-Mre11 protein are monomeric in the absence of Rad50 (41.4 and 40.9 kDa, 
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respectively, with a calculated MW for the monomer of 39.1 kDa).  As suggested by the 
competition assay, L101D-Mre11 forms a stable complex with Rad50 and has the expected 
molecular weight for a stable Mre112/Rad502 heterotetramer of 227.7 kDa (supplemental Fig. 
S2), with a calculated MW for the heterotetramer of 205.6 kDa.  A model containing an 
equilibrium between MR complex tetramers and dimeric and/or monomeric subunits was not 
required to produce small residuals.       
Nuclease Activity – The ssDNA endonuclease activity was probed using a circular M13 
substrate.  As shown in Fig. 2C, under these conditions neither WT-Mre11 nor L101D-
Mre11 alone is effective as an ssDNA endonuclease.  However, in the presence of Rad50, 
even in the absence of ATP, the endonuclease activity of both the WT- and L101D-MR 
complex is apparent.  The Rad50-induced enhancement of endonuclease activity is another 
indication that the L101D mutation does not affect the ability of Mre11 to bind to Rad50.  
Additionally, the mutation does not appear to have a significant impact on the ssDNA 
endonuclease of the complex, consistent with results from the P. furiosus system (34).       
 The exonuclease activity of the WT and L101D-MR complexes were first 
investigated using a uniformly P-32 labeled 1.96 kb linear blunt-ended DNA substrate.  
Nuclease activity was detected by separating the substrate and products using TLC, 
visualized by exposure to a Phosphorimager plate, and quantified using ImageJ (Fig 2D).  
The WT-MR complex exonuclease activity was fit to an equation with single-exponential 
and linear terms: 
 
                    (Eq. 1) 
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The single-exponential represents the dsDNA exonuclease activity and the much slower 
linear phase presumably represents a ssDNA nuclease reaction.  The analysis provided a rate 
of 9.9 ± 1.2 nts removed per second.  Because the slow linear phase was less apparent 
compared to the WT reaction (likely due to the slower exponential phase), the data for the 
L101D-MR complex were fit to a simple single-exponential equation:  
 
              (Eq. 2). 
 
The determined rate constant for the L101D-MR complex was 1.1 ± 0.1 nts removed per 
second.   
 The steady state nuclease activity was then assayed using a denaturing PAGE gel to 
visualize the product profile of a 50 bp hexachlorofluorescein labeled DNA substrate (Fig. 
3A).    The ATP-dependent activity produces short DNA products (i.e., less than 10 nts) at 
the early time points, indicating that the WT-MR complex is reasonably processive.  The 
L101D-MR complex does not appear to have the same level as processivity.  It does, 
however, appear to be more efficient at initiating the nuclease reaction compared to the WT-
MR complex, as judged by the more rapid loss of the 50 bp DNA substrate.  We also 
monitored the steady state exonuclease activity of the WT- and L101D-MR complex using a 
real-time fluorescent assay using 2-AP as a reporter for nucleotide removal.  Liberation of 
the 2-AP from the dsDNA substrate results in a large increase in fluorescence at 375 nm.  We 
placed 2-AP probes at various positions along the DNA substrate and followed their removal 
at saturating concentrations of ATP.  As seen in Fig 3B, the L101D-MR complex 
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outperforms the WT-MR complex at each 2-AP position by a range of 4 to 13-fold, 
consistent with the PAGE analysis.   
In contrast to the ATP-dependent exonuclease reaction, in the absence of ATP, the 
L101D-MR complex has lower activity compared to the WT-MR complex.  PAGE analysis 
of the nuclease reaction (Fig. 4A) indicates that while the L101D-MR complex appears to 
initiate the nuclease reaction normally (a single cut is seen at the first time point), it is very 
slow to make subsequent nucleotide excisions.  The ATP-independent exonuclease reaction 
carried out by the WT-MR complex appears less processive than in the presence of ATP, but 
DNA products of less than 10 nts in length are still observed starting at approximately the 50 
minute time point.   The 2-AP fluorescence assay (Fig. 4B) is consistent with the PAGE 
analysis, when the 2-AP probe is at the 1
st
 position the WT- and L101D-MR complexes have 
nearly identical exonuclease rates.  However, when the 2-AP probe is moved away from the 
3’ end, the exonuclease activity of the WT-MR complex exceeds that of the L101D-MR 
complex.    
  We next examined the pre-steady state exonuclease activity of the WT- and L101D-
MR complex.  The product profile of the ATP-dependent reaction was visualized using 
denaturing PAGE.  In the pre-steady state reaction, the concentration of protein is held in a 
30-fold excess over the concentration of DNA substrate.  As shown in Fig. 5A, similar 
patterns are seen in the pre-steady state product profile as were seen in the steady state assay 
(Fig. 3A).  The WT-MR complex produces products of the final length (distributed around 5 
nts) even at the earliest time-point.  Because no intermediate lengths of product DNA are 
observed, we tested the possibility that the products are the result of an endonuclease activity 
cutting approximately ~5 bp from the 5’ P-32 label instead of the expected 3’ to 5’ 
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exonuclease activity.  We performed a reaction under identical conditions but used a DNA 
substrate containing a phosphorothioate linkage 24 nts away from the 3’ end.  As seen in Fig 
5B, a build-up of products is seen at the exact position of the phosphorothioate linkage, 
indicating that the products produced in Fig. 5A are the result of exonuclease activity.  The 
pre-steady state product profile of the L101D-MR complex reaction mirrors that of the steady 
state reaction.  In contrast to the WT-MR complex, intermediate lengths of DNA are 
observed between the full-length DNA substrate and the final product.  The smallest product 
in the L101D reaction does not appear until approximately the 30 second time point and a 
progressive decrease in product length is observed with increasing time.  
 We also employed the 2-AP probe to monitor the ATP-dependent pre-steady state 
exonuclease activity of the WT- and L101D-MR complexes in using stopped-flow 
fluorescence.  The 2-AP probe was placed at either the 1
st
 or 12
th
 nucleotide relative to the 3’ 
end of the DNA substrate.  As seen in Fig. 6, the results mirror that of the pre-steady state 
reactions analyzed using denaturing PAGE.  The WT-MR complex is significantly slower 
than the L101D-MR complex at removing the 2-AP probe located at either the 1
st
 or 12
th
 
position (Fig. 6A and 6B, blue traces); however, the WT-MR complex product curve using 
the 12
th
 position DNA substrate displays no lag period (Fig 6A, red trace), whereas a 
prominent lag is observed in the L101D-MR complex reaction (Fig. 6B, red trace).      
Discussion 
  It is thought that the Rad50 and Mre11 subunits of the MR complex are allosterically 
coupled to each other (24, 25, 27, 28, 38).  X-ray crystal structures and protein-protein 
crosslinking experiments have demonstrated that ATP binding and/or hydrolysis by Rad50 
affects the conformation of Mre11 (25, 27).  Our data has shown that the communication 
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between Rad50 and Mre11 is bidirectional, with Mre11 affecting the catalytic activity of 
Rad50 (18).  WT-Mre11, along with dsDNA, increases the ATP hydrolysis activity of T4 
Rad50 by approximately 20-fold (18).  A similar degree of activation (20-fold) is observed 
with nuclease-deficient Mre11 mutants, indicating that the activation is not directly related to 
the nuclease activity of Mre11
2
.  However, this allosteric activation by DNA may not be 
general to MR complexes from all species.  The ATPase activity of the MR complex from P. 
furiosus is unaffected by addition of dsDNA (39), although it is unclear if the lack of 
activation is due to the absence of a zinc-hook in the mutant Rad50 protein that was used.  
We have found that in the T4 system, site-directed mutation of the zinc-hook completely 
eliminates the DNA activation of the ATPase activity
3
.  In contrast to WT-Mre11, L101D-
Mre11 only activates Rad50 ATP hydrolysis two-fold in the presence of dsDNA.  This 
decrease in activation is not due to a decrease in the stability of the complex because 
nuclease, Rad50 competition, and AUC experiments all indicate that the affinity of L101D-
Mre11 for Rad50 is unaffected by the mutation.  DNA binding experiments also indicate that 
the L101D-MR complex has normal affinity towards dsDNA.   
The decrease in DNA activation of the L101D-MR complex suggests that when DNA 
is present, there is a tight coupling between the altered structure of the Mre11 dimer interface 
and the structure/activity of Rad50.  On the other hand, the ATPase activity of the L101D-
MR complex is nearly normal without DNA, suggesting that the tight coupling between 
Mre11 and Rad50 requires the formation of the MR-DNA complex.  Alternatively, it is 
possible that the Mre11 dimer interface only forms in the presence of dsDNA so that the 
introduction of the L101D mutation has no effect on the conformation of Mre11 in the 
absence of DNA.  However, the available crystal structures of the MR complex argue against 
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this possibility since they have all shown a dimeric Mre11, regardless of the presence or 
absence of a bound DNA substrate (25, 28, 34, 36, 37).   
 The ATP-independent nuclease activity of L101D-Mre11 on ssDNA (Fig. 2C) and 
dsDNA with the 2-AP probe at the 1
st
 position (Fig. 4B) demonstrates that the intrinsic 
nuclease activity of L101D-Mre11 is unaffected.  This indicates that the Mre11 active site is 
unperturbed, suggesting that the conformation of the L101D-Mre11 subunit itself is not 
greatly affected by the introduction of the negative charge into the dimer interface.  However, 
the ATP-dependent exonuclease activity of the L101D-MR complex, when assayed using a 
1.96 kb dsDNA substrate, is reduced by 9.2-fold (Fig. 2D). Since the intrinsic nuclease rate 
of L101D-Mre11 appears to be normal, the reduction in repetitive exonuclease activity is 
likely caused by a reduction in processivity or the translocation rate, which may be linked to 
the reduced ATP hydrolysis of the L101D-MR-DNA complex.     
Based on the decrease in exonuclease activity of the L101D-MR complex when 
assayed with the 1.96 kb DNA substrate, we were surprised to observe elevated nuclease 
rates when assayed with the 50 bp dsDNA substrate.  In the presence of ATP, the L101D-MR 
complex displays higher activity than the WT-MR complex when the 2-AP nuclease probe is 
placed at positions ranging from 1 to 22 (Fig. 3B).  We have previously determined the rate-
limiting step of the steady state nuclease reaction to be the productive assembly of the MR 
complex onto the DNA substrate (31, 38).  Therefore, the higher activity of the L101D-MR 
complex suggests that its productive assembly rate is increased compared to the WT-MR 
complex.  We are using the term “productive assembly” to represent an event that differs 
from simple DNA binding.  Our DNA binding assays indicate that the L101D-MR complex 
has nearly identical affinity for duplex DNA as the WT-MR complex.  Additionally, a 
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comparison of the ATP hydrolysis to the exonuclease rates suggests that the WT-MR 
complex likely undergoes several rounds of unproductive binding events prior to successfully 
removing the first nucleotide from the DNA substrate (the kcat’s for ATP hydrolysis and 1
st
 
nucleotide removal are 3.2 and 0.15 s
-1
, respectively).   
The PAGE analysis of a 5’ labeled DNA substrate is consistent with a faster assembly 
rate and also reveals that the processivity of the L101D-MR is greatly reduced compared to 
the WT-MR complex (Fig. 3A).  In the WT-MR complex reaction, very few intermediates 
are observed between the full-length DNA substrate and the final products that are less than 
10 nts in length.  This pattern is highly indicative of a slow rate-limiting assembly step, 
followed by a rapid (relative to the acquisition time) and processive exonuclease reaction.  
On the other hand, in the case of the L101D-MR complex, the pattern is more indicative of 
rapid assembly and a rate-liming nucleotide excision or translocation step (Fig. 3B).  Since 
the intrinsic nuclease activity of the L101D-MR complex is unaffected, it suggests that the 
defect lies in the translocation step that follows nucleotide excision.  Also, the L101D-MR 
complex does not excise as many nucleotides from the DNA substrate as the WT enzyme 
(i.e., the smallest product for WT is approximately 3 nts, whereas for L101D it is 
approximately 6 nts).  The cause of this difference is not clear, but it is possible that the size 
of the DNA remaining is simply related to the melting temperature of the DNA strand and 
the speed at which the MR complex moves along the DNA substrate (i.e., the WT complex 
excises more nucleotides prior to DNA strand melting due to its higher processivity and 
speed of translocation).  This explanation is consistent with the production of a range of 
products rather than a single discreet band.   
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 The more rapid assembly of L101D-MR complex as compared to the WT complex is 
difficult to explain within the context of an Mre11 dimer interface that is stable and 
unchanging throughout the nuclease reaction cycle.  The x-ray crystal structures of the 
truncated MR complex in the absence and presence of ATP suggest minor changes in the 
Mre11 dimer interface and biochemical experiments suggest a dynamic interface as well (25, 
27).  Protein cross-linking experiments performed in the Hopfner laboratory indicate that 
binding of ATP to the MR complex alters the conformation of the Mre11 dimer interface 
leading to a decrease in cross-linking efficiency (27).  Inclusion of ADP rather than ATP 
increases cross-linking efficiency, indicating that ATP and ADP stabilize different forms of 
the Mre11 dimer interface.  It is unclear whether the L101D mutation is stabilizing the apo, 
ADP, or ATP form of the Mre11 dimer interface, or if it produces an alternative 
conformation that the WT-MR complex does not normally adopt during its nuclease cycle.  It 
is tempting to speculate, however, that because L101D-MR complex has a more rapid 
productive assembly rate and a normal intrinsic nuclease rate, the mutation stabilizes the 
native conformation of the MR complex that is most competent for initiation of nuclease 
activity.   
 The pre-steady state kinetic data is also consistent with a slow rate-limiting assembly 
of the WT-MR complex, followed by a rapid and processive exonuclease reaction.  In the 
reaction shown in Fig. 5A the ratio of protein to DNA is 30:1 and the reaction rate has 
reached a protein-independent phase, such that increasing the concentration of protein has no 
effect on the apparent rate of the reaction.  Even at these extremely high protein 
concentrations, the product pattern is similar to that seen in the steady state nuclease reaction 
shown in Fig. 3A.  The absence of observable intermediates in the pre-steady state WT 
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reaction indicates that the rate-limiting step remains productive assembly, even under high-
protein conditions.   
The shape of the product formation curve in the pre-steady state stopped-flow 
experiments (Fig. 6A and 6B) also provides information regarding the rate-limiting steps of 
the nuclease reaction.  In the situation where productive assembly is fast compared to the 
translocation/nuclease rate, a distinct lag phase should be seen as the probe is moved away 
from the 1
st
 position, analogous to what is often observed in all-or-none helicase unwinding 
assays (40).  This is precisely what is observed in the L101D-MR complex reaction, 
consistent with the conclusions from the steady state and pre-steady state PAGE analysis.  
On the other hand, the product formation curve of the WT-MR complex shows no apparent 
lag as the probe is moved away from the 3’ end of the DNA.  Again, as the PAGE analysis 
suggested, this is consistent with a rate-limiting productive assembly step, followed by rapid 
exonuclease activity and translocation. 
 Based on the data presented here, we propose a two-state working model for the 
Mre11 dimer interface (Fig. 7).  The first state (the ‘nuclease initiation state’) forms during 
the initiation of nuclease activity and is promoted by the L101D mutation.  The second state 
(the ‘translocation state’) forms during the processive exonuclease reaction, likely an ATP 
hydrolysis-driven translocation step, and is hindered by the L101D mutation.  The exact 
nature of the Mre11 dimeric interface in these two states is unknown.  Given the extreme 
nature of the Leu
101
 to Asp mutation, it is tempting to speculate that in the nuclease initiation 
state, the Mre11 dimeric interface is altered in such a way as to remove the leucine residue 
from the hydrophobic pocket that is observed in the x-ray crystal structures.  We propose that 
the Mre11 dimeric interface that has been repeatedly observed in the x-ray crystal structures 
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(i.e., with Leu
101
 engaged in the hydrophobic pocket) is the conformation of the translocation 
state.    
Our current working model for the Mre11 interface has the WT-MR complex 
sampling both states when not bound to DNA, with the equilibrium lying in the direction of 
the translocation state.  This equilibrium is included in the model to explain the observation 
that the DNA-dependent ATP hydrolysis rate is much faster than the steady state nuclease 
rate (i.e., all binding events result in ATP hydrolysis, but only a few result in the excision of 
a nucleotide from the DNA substrate).  Following productive assembly, the MR complex 
remains in the ‘initiation state’ for the removal of the nucleotide from the 3’ end of the 
dsDNA.  If nucleotide excision occurs in the absence of ATP, a portion of the WT-MR 
complex dissociates from the DNA, where it can rebind DNA substrate to excise another 
nucleotide (non-processive translocation).  The release of the DNA by the MR complex may 
involve a conformational change in the Mre11 dimer interface, since the L101D-MR 
complex appears to stall on the DNA substrate in the absence of ATP, rather than releasing it 
with the same rate at the WT-MR complex (see Fig. 4). After nucleotide excision in the 
presence of ATP, ATP hydrolysis by the WT-MR complex triggers a conformational change 
to ‘translocation state’ and the complex translocates along the nascent ssDNA in preparation 
for the next nucleotide excision.  The translocation step itself could occur following either 
ATP hydrolysis or ADP/Pi product release.  After the translocation step, the WT-MR 
complex returns to the ‘nuclease initiation state’ to complete the cycle.  The L101D-MR 
complex binds and hydrolyzes ATP (albeit at a slower rate than WT), but because it is unable 
to form the ‘translocation state’ it dissociates from the DNA rather than moving forward for 
the next nucleotide removal, hence its lower processivity. 
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As previously suggested by Hopfner and colleagues (27), a model involving repetitive 
conformational changes in Mre11, which are driven by Rad50 ATP hydrolysis, is reminiscent 
of how the NBD of ABC transporters drive the opening and closing of their transmembrane 
domain to allow substrates into or out of the cell (16).  This is consistent with the notion that 
all members of the ABC protein super-family share a unified functional architecture (19, 27). 
In the S. pombe system, Nbs1 binding to Mre11 causing several conformational 
rearrangements in the Mre11 dimer interface (35).    
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Footnotes 
 
1
The abbreviations used are: T4 phage, bacteriophage T4; DSB, double-strand break; 
HR, homologous recombination; gp46, T4 gene product 46; gp47, T4 gene product 47; 2-AP, 
2-aminopurine deoxyribonucleotide; MR, Mre11/Rad50; IR, ionizing radiation; NBD, 
nucleotide binding domain; ssDNA, single-stranded DNA; dsDNA, double-stranded DNA; 
HEX, hexachlorofluoroscein;  ABC, ATP binding cassette; ssDNA, single-stranded DNA; 
dsDNA, double-stranded DNA; MR-DNA, Mre11/Rad50-DNA complex; PDBid, protein 
data bank id; WT, wild-type.  
2
Albrecht and Nelson, unpublished observations.  
3
Barfoot and 
Nelson, unpublished observations. 
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Table 1 
 
 
Steady state ATPase Kinetic Constants for WT and L101D MR-DNA Complexes
a
 
 
 
 
 
a 
Fluorometric assays were performed in 50 mM Tris-HCl, 50 mM KCl, 0.1 mg/ml BSA (pH 7.6) in the 
presence of 5 mM MgCl
2
 at 30 °C.  Values determined by fitting data to a Hill equation.  Errors represent the 
standard error of the fit.  
b 
Fold increase in k
cat
 between MR-DNA and Rad50.  
c
 Values from reference (18). 
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Table 2 
 
 
Dissociation constants for dsDNA and ssDNA
a
 
 
 
 
 
 
a
 Polarization assays were performed in 50 mM Tris-HCl, 50 mM KCl, 0.1 mg/ml BSA (pH 7.6) in the presence 
of 5 mM MgCl
2
 at room temperature.  Protein concentrations ranged from 0 to 12 µM in each reaction with a 
DNA concentration of 10 nM.  Assays containing ATP had concentrations of 0.25 mM and 0.185 mM for WT 
and L101D, respectively.  Values determined by fitting data to simple equilibrium binding mechanism using 
SigmaPlot software. 
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Table 3 
Oligomeric determination of the WT and L101D-Mre11 and Mre11/Rad50 Complex
a
. 
 
 
 
a
 Analysis performed using the Sedphat software.  Global fits were accomplished with the Simplex fitting 
algorithm.  MW estimates were derived from a Monte-Carlo simulation for non-linear analysis.  The MW 
values reported are the average of the derived estimates of three protein concentrations.  Errors are the standard 
deviations of the derived estimates of the three protein concentrations.  
b
 Deduced MW for Mre11 is 39,168 Da.     
c 
Deduced MW for the (Mre11)2/(Rad50) 2 complex is 205,568 Da. 
 
  
Protein MW (Da) 
WT-Mre11
b 
 41,463 ± 769 
L101D-Mre11
b
 40,904 ± 1,679 
WT-Mre11/WT-Rad50
c
 204,717 ± 7,878 
L101D-Mre11/WT-Rad50
c
 227,706 ± 8,614 
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Figure 1.  The MR complex heterotetramer with truncated Rad50 coiled-coil domains.  The ribbon 
structure is based on PDBid 3THO (25).  The Rad50 subunits are colored cyan and green and the Mre11 
subunits are colored blue and yellow.  The Mre11 dimer interface is indicated.  Two molecules of ATP bind at 
the Rad50 interface and the Mre11 nuclease active site is indicated by the purple spheres representing the active 
site Mn
2+
 ions.        
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Figure 2.  A) Close-up view of the modeled T4 Mre11 dimer interface.  The homology model was generated 
using the Swiss Model server (39) and based on PDBid 3DSC (36).  B) Competition assay for Rad50.  Each 
spectrophotometric ATPase assay consisted of the standard buffer with 0.1 µM WT-Mre11, L101D-Mre11 at 
the concentration indicated, 0.1 µM Rad50, 1 mM ATP, and 1.0 µM 50 bp dsDNA. C) ssDNA endonuclease 
activity assays.  The four time points for each indicated condition are 0, 8, 16, and 32 minutes.    D) Blunt-
ended dsDNA exonuclease activity assays.  Assays were performed in standard buffer with 0.3 mM MnCl2 at 
30 °C.  ATP concentrations of 0.25 mM and 0.185 mM were used for WT and L101D, respectively.  Each assay 
consisted of 1 µM Rad50, 1.25 µM Mre11, and 5 nM DNA substrate.  Time points were 0, 1, 2, 4, 8, 16, and 32 
minutes. 
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Figure 3.  Steady state exonuclease activity in the presence of ATP.  A) Visualization of nuclease products on 
a 16% Urea-PAGE gel is shown.  Each assay consisted of the standard buffer with 0.3 mM MnCl2, 100 nM 
Rad50, 105 nM Mre11, and 1.3 µM DNA substrate.  Time points for each protein are 0, 5, 10, 15, 20, 30, 40, 
50, 60, 70, 80, 90, 100, 110, and 120 minutes.  The first and final lanes are no protein controls. Approximate 
mobility of various DNA lengths are shown on the right-hand side of the gel.  B)  A plot of the kcat-exonuclease 
for either the WT-MR complex (closed diamonds) or the L101D-MR complex (closed squares) with the 2-AP 
probe at various positions along the DNA substrate relative to the 3’ end.  Protein, DNA, and ATP 
concentrations are given in “Experimental Procedures”.  
B. 
A. 
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Figure 4.  Steady state exonuclease activity in the absence of ATP.  A)
 
Visualization of nuclease products on 
a 16% Urea-PAGE gel is shown.  Each assay consisted of the standard buffer with 0.3 mM MnCl2, 200 nM 
Rad50, 210 nM Mre11, and 1.3 µM DNA substrate.  Time points for each protein are 0, 5, 10, 15, 20, 30, 40, 
50, 60, 70, 80, 90, 100, 110, and 120 minutes.  The first and final lanes are DNA standards with lengths of 50, 
40 30, 20, and 10 nts.  B) A plot of the kcat-exonuclease for either the WT-MR complex (closed diamonds) or 
the L101D-MR complex (closed squares) with the 2-AP probe at various positions along the DNA substrate 
relative to the 3’ end.  Protein, DNA, and ATP concentrations are given in “Experimental Procedures”.    
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Figure 5.  Pre-steady state exonuclease activity in presence of ATP visualized with urea-PAGE.
  
A) Assay 
using standard 50 bp substrate with biotin/streptavidin blocking the 3’ end of ds50-R.  Each assay consisted of 
the standard buffer with 0.3 mM MnCl2, 3 µM Rad50, 3.15 µM Mre11, and 100 nM DNA substrate.  Time 
points for each protein are 0, 3, 5, 7, 10, 15, 20, 25, 30, 40, 50, 60, 80, 100, and 120 seconds.  B) Assay using 50 
bp substrate with biotin/streptavidin blocking the 3’ end of ds50-R and a phosphorothioate linkage at position 
26 on ds50-F.  The conditions and time points were identical to those in A) except that the 40 second time point 
was omitted from WT-MR complex reaction.    
B. A. 
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Figure 6. Pre-steady state exonuclease activity in presence of ATP monitored using stopped-flow 
fluorescence and 2-AP containing DNA substrates.   The assays were carried out at 30
o
C in the standard 
buffer with 0.3 mM MnCl2.   The blue and red traces are the exonuclease activity using the 50 bp DNA 
substrate with the 2-AP probe located at the 1
st
 and 12
th
 positions, respectively, relative to the 3’ end of the 
DNA.  A)  The exonuclease activity of the WT-MR complex. Each assay consisted of 1 mM ATP, 200 nM 
DNA, and 3 µM WT-MR complex.  B) The exonuclease activity of the L101D-MR complex.  Each assay 
consisted of 1 mM ATP, 200 nM DNA, and 2 µM L101D-MR complex.   
 
A. 
B. 
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Figure 7.  Proposed two-state model for the Mre11 dimer interface based on studies of the T4 MR 
complex (gp46/47).  Details of the model can be found in the text of the Discussion.  A legend can be found in 
the lower left-hand corner.  The small purple circle found on each Mre11 subunit represents the nuclease 
activity site.  The ‘initiation state’ of the MR complex is depicted as having a parallel Mre11 dimeric interface 
and the ‘translocation state’ is depicted with the Mre11 dimer interface in close contact at one end (V-shaped).      
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Supplemental Figure 1. Circular dichroism spectra of WT- and L101D-Mre11 proteins.  The experiment 
was carried out as described in “Experimental Procedures”. 
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Supplemental Figure 2.  Oligomeric determination of the WT Rad50/L101D Mre11 complex.   
Representative analytical equilibrium ultracentrifugation results for one complex concentration (initial 
A280: 0.6).  Equilibrium concentration gradients were formed at velocities of 11 600 (◊), 13 800 (□), and 
15 800 rpm (∆).  Solid lines represent the global fits produced.  Inset: fit residuals. 
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Chapter IV:  Conclusions 
Summary 
 The data presented in Chapter II provides for the first time a biochemical 
characterization of T4 Mre11 and Rad50 complex, which had been the only remaining 
proteins involved in T4 phage recombination and DSB repair left uncharacterized.  The MR 
complex in T4 phage is shown to have conserved properties with its homologs in other 
organisms.  It has ATPase, endonuclease, and exonuclease and DNA binding activities.   
 The ATPase activity of Rad50 is quite low by itself (kcat of 0.15
 
s
-1
).  However, upon 
the addition of Mre11 and dsDNA the activity is increased by ~22 fold and the Hill 
coefficient increases from 1.4 to 2.4 suggesting that Mre11 and DNA act as activators for 
Rad50’s catalytic activity and may promote communication between the two nucleotide 
binding domains of Rad50. 
The nuclease activity of the MR complex is shown to be in the Mre11 subunit and 
ssDNA endonuclease, dsDNA exonuclease, and dsDNA endonuclease activity are all 
observed.  The dsDNA exonuclease activity seen is in a 3’ to 5’ direction which does not 
agree with the suggested in vivo activity of the MR complex.  This has similarly been 
observed in S. cereviseae (1).  This disagreement in polarity may result from the absence of 
accessory proteins required for the 5’ to 3’ activity and/or metal dependence of the nuclease 
reaction.  We have shown that Mg
2+
-dependent nuclease assays containing UvsY and gp32 
may allow the MR complex to produce a 3’ overhang through a 5’ to 3’ endonuclease 
activity.   This phenomenon is not yet completely understood and may require further 
investigation to fully comprehend.  Similar to the activation seen in Rad50 ATPase activity, 
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there is an increase in Mre11 nuclease activity in the presence of Rad50.  Mre11 does 
degrade DNA without Rad50, but the activity is ~100 fold lower.  This implies a 
bidirectional communication between the subunits of the MR complex. 
 The introduction of a leucine to aspartic acid mutation at the dimer interface of Mre11 
has provided interesting insight into the importance of this dimeric interaction.  Initially, we 
found that the mutation had little effect on some of the properties of the MR complex.  Our 
studies have shown that the L101D-Mre11 mutant is able to bind to Rad50 with a similar 
affinity as wild-type.  Also, the L101D-MR complex appears to have the same stoichiometry 
(M2/R2) as the wild-type complex.  Similarly, the L101D mutation appears to have no impact 
on the DNA binding properties.  Both wild-type and L101D-Mre11 had no measureable 
binding to dsDNA.  However, upon addition of Rad50 binding was seen and the Kd values 
were similar between the two complexes (0.69 and 0.62 µM for wild-type and L101D-MR 
complexes, respectively).  The addition of ATP brought about tighter binding (0.15 and 0.13 
µM for wild-type and L101D-MR complexes, respectively).  Binding properties for ssDNA 
followed similar trends. 
 Major differences were seen, however, in the ATPase and the exonuclease assays.  
The L101D-MR complex had a near-normal ATPase rate in the absence of dsDNA.  
However, Rad50 only had a 2.2 fold increase in ATPase activity upon the addition of 
L101D-Mre11 and dsDNA suggesting that the L101D mutation has somehow disrupted the 
communication between Mre11 and Rad50 in the presence of DNA.  In the exonuclease 
assays performed the L101D-MR complex appeared to have a greatly reduced processivity 
compared to wild-type.  This does not appear to come from the loss of exonuclease activity 
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due to nuclease rates at or above wild-type rates on 2-aminopurine assays probing the 1
st
 
position.  
 The possibility of multiple Mre11 conformational states has been previously proposed 
based on structural data (2, 3).  Based on our data we have proposed a model for the MR 
complex that has Mre11 utilizing at least two states which we have termed the “nuclease 
initiation” and “translocation” states.  The nuclease initiation state is stabilized by the L101D 
mutation and the translocation state is inhibited by the L101D mutation.  Prior to DNA 
binding the MR complex is in equilibrium between the nuclease initiation and translocation 
states with the equilibrium favoring the translocation state.  Once productive assembly is 
reached the MR complex removes a nucleotide from the 3’ end of the dsDNA and, if ATP is 
present, a conformational change to the translocation state occurs.  The complex then moves 
along the DNA to position itself near the next nucleotide.  It is not yet clear if the switch to 
the translocation state occurs after ATP hydrolysis or ADP/Pi release.  After completion of 
the translocation step the complex returns to the nuclease initiation step.  The L101D-MR 
complex is stabilized in the nuclease initiation step and it unable to form the translocation 
state.  Therefore it must dissociate after each nuclease reaction and rebind to the DNA giving 
it its lower level of processivity.  In the absence of DNA the MR complex partially 
dissociates from the DNA and is able to rebind to excise another nucleotide. 
Future Direction 
It has been shown in the literature that the MR complex is essential for the initial 
resection in eukaryotic DSB repair (4, 5).  However, it recently has been shown that resection 
of unmodified DNA ends does not require the active MR nuclease complex and that the MR 
complex may play a structural role in this type of resection (4, 5).  RNase H1 has been shown 
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to remove RNA primers during Okazaki fragment processing and it has also been suggested 
that it is involved in DNA resection (6, 7).  This has prompted our lab to explore the 
possibility that RNase H1 is involved in DSB resection in T4 phage.  We plan to perform the 
in vitro assays necessary for investigating this possibility while our collaborators at the 
Kreuzer lab at Duke University plan to perform the in vivo work. 
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